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Abstract
Paratuberculosis (Johne's disease) is a chronic intestinal disease of
ruminants caused by Mycobacterium avium subspecies paratuberculosis
(MAP). Three forms have been described in sheep — multibacillary,
paucibacillary and asymptomatic. Real-time RT-PCR (qPCR) and
microarray analyses were used to compare gene expression in ileal tissue
from sheep with the three forms of the disease in order to understand the
immune responses underpinning these three defined pathologies. All
animals from the infected flocks were IS900 positive by qPCR and
therefore infected with MAP. Asymptomatic sheep had no clinical signs of
disease, showed no evidence of acid-fast bacteria (ZN-), exhibited normal
histology of the terminal ileum and were seronegative. Paucibacillary
sheep were ZN- and showed lymphocyte/eosinophil infiltrate into the
lamina propria. 2/6 of the paucibacillary animals were seropositive.
Multibacillary sheep had high numbers of ZN+ bacteria associated with
infiltrating sheets of epithelioid macrophages and were seropositive.
Control sheep were IS900 negative and thus uninfected with MAP.
qPCR experiments compared the expression of the following genes
- IL-la, IL-1B, IL-3, IL-6, IL-8, IL-10, IL-12p40, IL-18, CD34, CXCR4,
GM-CSF, IFNy, IGFBP-2, IGFBP-6, TGF6, TIRAP, TNFa, TRAF-land
TRAM. The results confirmed that pauci- and multibacillary forms are
linked to the differential expression of IFNy and IL-10 respectively, but
imply that polarisation is incomplete, with upregulation of both
proinflammatory IL-18 and anti-inflammatory TGFB in both disease
forms. Increased levels of the proinflammatory cytokines IL-ip, IL-8,
TNFa and TRAF-1, indicative of persistent inflammatory lesions, were
observed in clinical tissues. IL-3 was detected at low levels in all infected
animals but never in uninfected control samples. IGFBP-6 was up-
regulated and CXCR4 down-regulated in paucibacillary samples
IV
compared to multibacillary samples. SNP analysis was carried out on
these genes, identifying three novel SNPs in each gene, but none were
linked to disease pathology.
Microarray experiments discovered 63 differentially expressed
genes. Four genes were found to be differentially expressed in infected
tissue compared to uninfected controls, and a further eight in clinical
tissues compared to uninfected controls. Eight genes were differentially
expressed in clinical tissue compared to asymptomatic tissue. Seven
genes were quantified by qPCR and validated the microarray data well.
Pathway analysis of the microarray data identified several immune
pathways that are involved in pathogenesis. Infected tissues displayed
up-regulation of the genes involved in complement activation, and down-
regulation of TCR signalling and MHC class II genes. In addition,
clinical tissues displayed up-regulation of genes involved in the JAK-
STAT and TLR2 signalling pathways, NK cell cytotoxicity and antibody
production. Multibacillary tissues also displayed up-regulation of genes
involved in leukocyte migration.
Overall, these data confirm that multibacillary pathology is linked
to type 2 and paucibacillary pathology is linked to type 1 immune
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1.1.1 Symptoms and Pathology
Paratuberculosis (Johne's disease) is a chronic inflammatory disease
ointhe gut of ruminants, caused by infection with Mycobacterium avium
subspecies paratuberculosis (MAP). It is characterised by granulomatous
enterocolitis, lymphangitis and lymphadenitis (52). After infection, sheep
display a long asymptomatic phase of up to two years (6) after which
clinical symptoms may develop. These symptoms are wasting, diarrhoea,
loss of condition and eventual death, caused by inflammation of the
intestine leading to lower absorbance of water and nutrients (6,231). The
main site of infection and pathogenesis is the ileum, and several forms of
the disease have been previously described (41,231) based on gross
pathology of the gut (Figure l.l). These forms are similar to the
pathologies of human leprosy (55) and can be unambiguously
differentiated into paucibacillary (tuberculoid), multibacillary
(lepromatous) and asymptomatic (infected but no pathology) (53). What
determines which of these three forms of the disease develops is
unknown, but it may be related to the genetic background of the host (35).
Asymptomatic individuals come from flocks with endemic
paratuberculosis and are infected with the mycobacteria, but have no
clinical symptoms and no signs of intestinal pathology (224).
On examination of the gut of paucibacillary animals, a slight thickening
of the intestine can be observed. Histopathological examination reveals a
large lymphocytic infiltrate and the presence of multinucleated giant
cells. Few mycobacteria can be seen in Ziehl'Neelsen (ZN) stained tissue.
The mucosal surface is flattened, and normal villus architecture
interrupted. Paucibacillary lesions contain many lymphocytes, with very
















Figure 1.1: Anatomy of the ovine intestinal tract, showing the position of the ileum where the
majority of paratuberculosis pathology is found.
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When the gut of multibacillary animals is examined, the small intestine
is thickened and may be pigmented. Histopathological examination
reveals a large macrophage infiltrate, with few or no giant cells. Large
numbers of bacteria can be seen in ZN stained tissue. Again, the mucosal
surface is flattened, and normal villus architecture interrupted
(56,90,231,249).
1.1.2 Prevalence and costs
The worldwide prevalence of paratuberculosis is a subject that attracts
much attention and research, but there is as yet very little solid
information available. The information can be split into two different
types - herd or flock level prevalence i.e. the percentage of herds or flocks
with any level of paratuberculosis, and the prevalence of infection in
individual animals. A recent study in cattle concluded that worldwide,
the herd level prevalence in cattle ranged from 0% to 71% (155). In the
USA, herd level prevalence in cattle ranges from 20-40%, depending on
herd size and geographical location (10,88,95,142). Across Europe,
estimates of herd level prevalence vary widely. In the UK, prevalence
ranges from 3.5-17%, depending on detection method (95,225). In other
European countries, the herd level prevalence estimates are as follows^
The Netherlands 31-71%; Denmark 47-70%; Germany 20%; Belgium 8-
27%; Spain 12-18%; Italy 11-13%, Switzerland 8%; Austria 7% and The
Czech Republic 12% (69,95,142,225). The herd level prevalence in New
Zealand is 60% (95). In Australia, the overall herd level prevalence is 15%
(95), but there is a great deal of variation between states — from 9% in
New South Wales to 22% in Victoria (10).
Prevalence estimates based on individual animals are even more variable
than herd based estimates, due to the asymptomatic nature of the disease
and the low sensitivity of some detection methods. In cattle estimates
range from 1.6-10% in the USA (230) to 30% in Brazil (189) and 11-84%
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in India (29,214). In sheep, prevalence has been estimated at 1.28% in
India (29); 2.83% in Galicia in Spain (69); 14-20% in Greece (134); 45% in
Italy (168) and less than 50% in Australia (l). However, many of these
studies focused on single flocks, or solely on asymptomatic sheep, and
thus may not be entirely reliable.
Based on these prevalence estimates, several studies have attempted to
calculate the actual cost of paratuberculosis. It is estimated to cost the
USA dairy industry $200-250 million per year (146,175). This is mainly
due to increased culling - Canadian cattle infected with MAP have 1.38
times the risk of being culled compared to non-infected cattle (246) and
lower milk, fat and protein yields (104). Studies have shown that cows
with clinical paratuberculosis produce 19.5% less milk and cows with sub¬
clinical paratuberculosis produce 16% less milk (24).
In Scotland in 1993-2002, there were 465 recorded cases of
paratuberculosis in all species (234). However, this figure only reflects
cases reported to Health Protection Scotland by veterinary laboratories,
which is not commonly done as paratuberculosis is not a notifiable
disease. A study taking into account herd sizes, milk prices, replacement
costs and average milk yields concluded that the cost of paratuberculosis
in the UK is about £26 per cow per year (238), although this increases
with milk prices. There is very little information as to the incidence or
cost of paratuberculosis in sheep.
1.1.3 Detection and diagnosis
Detecting infection with MAP before the onset of clinical symptoms with
associated bacterial shedding is problematic. If MAP infection could be
detected before the onset of faecal shedding and the infected animal
removed from the flock, this would prevent much of the spread of the
disease. Faecal culture is considered the 'gold standard' in detection, with
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high levels of sensitivity and specificity. This is, however, expensive and
can take up to twelve weeks (232). Culture of MAP also requires specific
conditions, including the addition of mycobactin J to the media, and
extensive decontamination of faecal samples (177). An alternative to
faecal culture is faecal smears, where the samples are smeared and
stained with a ZN stain to detect acid-fast bacteria. However, this method
is not as sensitive as culture due to the very low numbers of mycobacteria
present in the faeces of asymptomatic and paucibacillary animals (259).
Culture of intestinal tissue can also be used post-mortem to detect MAP
infection (240). Recent advances in faecal culture include the introduction
of BACTEC and MGIT rapid mycobacterial culture systems. The
BACTEC system is a radiometric culture system which involves culturing
MAP in a media containing a 14C substrate which is broken down into
radio-labelled carbon, which can be detected in the gas phase of the
culture vessel and allows 'real-time' measurement ofMAP growth (272).
The MGIT system works on a similar principle, but uses a fluorescent
substrate. Although these systems significantly reduce the time required
to culture MAP, the sensitivity can be as low as 13% compared to
traditional culture, and the contamination rate higher (99).
In Australia and New Zealand, animals slaughtered in abattoirs are
inspected for gross signs of paratuberculosis. This is a cheap and easy
way of detecting MAP infection within a flock. However, it has low
sensitivity for detecting flocks which have been recently infected, or that
have low levels of infection (l).
Several commercial ELISA based tests are currently available as a
method of detecting antibodies to MAP surface proteins in serum. The
sensitivity of these tests compared to faecal culture varies widely, from
13.7% where the animals would be classed as low shedders to 100% of
high shedders (75,151,248,255). However, as most animals would be
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classed as low shedders, current ELISA tests perform poorly overall
compared to faecal culture. Much work is currently being done to identify
new proteins in MAP to improve the ELISA tests (15,26,49,142), with
several having higher sensitivities than the currently available tests.
Other MAP detection methods available include an IFNy ELISA
(Bovigam, CSL) (187,237) which detects the increase in IFNy production
which occurs in preclinical animals infected with MAP. It is also possible
to carry out IFNy and proliferation assays by exposing PBMCs from
infected animals to PPD (162,165). However, a major drawback to these
kinds of tests is that the responses are time dependent. The IFNy
response, especially in sheep, is short-lived, and may not be detectable
after the initial peak at the time of infection. In goats, lymphocyte
proliferation tests can work from around day 60 post infection, whereas
ELISA tests may not work until 180 days post infection (162).
PCR-based tests are also becoming more widespread. The most common
PCR assays detect the presence of IS900 (50,90,232), and can be more
sensitive than faecal culture (116). It may also be possible to use PCR
based tests to detect MAP in samples infected with mixed M.avium
species (154). A recent study described a new method of DNA extraction
from faeces for PCR, giving a test with similar detection limits to culture
but higher sensitivity (258). However, PCR based tests simply detect the
presence of mycobacterial DNA in a sample, not the presence of viable
mycobacteria, and as such have to be used in conjunction with other
detection methods. This lack of agreement between tests for MAP
infection is a problem (8,152) which can only be overcome by using
various combinations of testing methods, with the associated increase in
cost and time taken for diagnosis. A second major problem with all tests
is that the age of the animal being tested can have an impact on the
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sensitivity of the test, with younger animals more likely to give false
negative results (171).
1.1.4 Control and treatment
The treatment of paratuberculosis is also difficult. Animals can be cleared
ofMAP infection by prolonged chemotherapy, but this is too expensive
and time-consuming for widespread use (78). The cost of MAP in the UK,
especially when milk prices are low, is not high enough to provide an
incentive for dairy farmers to control or treat the disease (238). Other
therapies, such as mycophage therapy, have been proposed but have not
proven to be effective (78). Currently, the majority of animals displaying
symptoms of paratuberculosis are culled.
The most cost-effective way of preventing paratuberculosis is by
vaccination. The current Gudair™ vaccine is a whole cell preparation of
heat-killed MAP (114). The vaccine elicits both humoral and cellular
immune responses (57), and studies in Australia have shown that
vaccination reduces mortality, faecal shedding and the numbers of
mycobacteria shed by up to 90% (185,274). There are, however, several
drawbacks to this vaccine. Approximately 50% of vaccinated animals will
develop a granulomatous lesion at the site of injection, which reduces
with age. A recent study concluded that this was a minor problem, as the
value of the carcase was not reduced by the presence of a lesion
(82,114,274). The vaccine induces the production of antibodies, which
prevents the differentiation of vaccinated and unvaccinated animals
(161). Vaccinated animals can also react with M.bovis skin tests, which
can lead to an increase in culling (148,169). Perhaps more seriously, of
the few vaccinated sheep that do go on to develop paratuberculosis, all
have the multibacillary form of the disease(l85,274). The vaccine is also
expensive and thus not economical on farms with low levels of the
disease. A study carried out in goats in India showed that vaccines
8
CHAPTER 1 INTRODUCTION
containing local strains of MAP were more efficacious and economical
than commercially available vaccines (221).
Due to these drawbacks with the currently available vaccine, there are
many studies underway looking to develop a new, improved vaccine. A
live modified vaccine has been shown to elicit a strong cellular immune
response, lasting over two years, along with a transient antibody
response. However, administration of this vaccine did lead to false
positive results in an Mycobacterium bovis screen (132,153). Other groups
have developed DNA plasmid vaccines expressing MAP proteins which
stimulate an appropriate immune response, and in one case has been
shown to protect against MAP infection in sheep (34,114,206). A
recombinant MAP Hsp70 vaccine has also been shown to reduce faecal
shedding in vaccinated cattle (130).
In flocks where the incidence of paratuberculosis is low, other control
strategies can be effective. Purchasing animals from uninfected flocks,
decontaminating lambing and weaning pastures by grazing management
and culling infected animals can be as effective as vaccination in reducing
MAP prevalence in flocks with low levels of infection (68).
1.2 Mycobacterium avium subspecies paratuberculosis
1.2.1 The M.avium clade
The genus mycobacterium consists of 71 species, many of which are
important pathogens of both humans and animals. All mycobacteria are
gram positive, although this stain does not work well. Mycobacteria can
easily be identified by staining with basic fuchsin — they are acid-fast and
thus will resist decolourisation by weak acids. This is due to the presence
of a thick cell wall, separated from the cell membrane by the periplasmic
space. This cell wall is made up of four layers — lipids, mycoloic acid,
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arabinogalactan and peptidoglycan. The various types of these molecules
can be used to differentiate mycobacterial species. The morphology of
mycobacteria is variable from short, round cells to long filaments. Several
species, including strains of MAP, produce yellow-orange
scotochromogens, leading to pigmented cultures (93).
Culturing mycobacteria can be difficult, and for some species, including
M.leprae, has never been achieved. In culture, all species require the
presence of oxygen, carbon and nitrogen sources, and metal ions including
iron. Some species have more specific requirements — MAP cannot be
grown without the addition of mycobactin to the media, for example. The
metabolic pathways in most mycobacteria were thought to be similar to
those in other bacterial species (93). However, new insights from genomic
and proteomic studies have shown that there are pathways unique to
mycobacteria, and that there is a great deal of variation in pathway use
between species (149).
The first division of mycobacterial isolates is into fast and slow growers —
fast growers, for example M.abscessus, produce visible growth in culture
within 7 days, whereas slow growers, for example M. tuberculosis, take at
least 7 days (91,93). Fast and slow growers can be differentiated by
staining with neutral red and then treating with alkali — slow growers
tend to resist decolourisation. 16s rRNA sequence can then be used to
classify isolates into the various species (91). All species, except
M. tuberculosis, have environmental strains (93). These environmental
strains tend to have more variable DNA sequences than pathogenic
strains (86).
The M.avium clade is composed of four species of slow growing
mycobacteria - MAP, M.avium subspecies avium, M.intracellulare and
M.silvaticum - which are 90% similar at the nucleotide level (94,159).
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These species differ in host species, pathogenicity and disease phenotype
(159). MAP was first cultured in 1912 on a modified egg media containing
heat killed M. tuberculosis to provide mycobactin (249). MAP takes 5-14
weeks to produce visible growth in culture and is differentiated from
other species in the clade by this mycobactin dependence (94,244). One
strain ofMAP has been sequenced and revealed to have a single circular
chromosome of 4 million base pairs, encoding 4350 predicted open reading
frames. Further analysis revealed that MAP has 4300 genes homologous
to genes in M. tuberculosis, with a truncation in the mycobactin gene
cluster (225). Strains of MAP are differentiated by restriction fragment
length polymorphism (RFLP) analysis of IS900, a specific insertion
sequence (178) or pulsed field gel electrophoresis (PFGE) of total genomic
DNA (225). Strains ofMAP can be divided into type I, comprising
pigmented ovine strains, and types II and III, comprising strains from a
wide range of hosts based on PFGE (66,233) and RFLP (178) profiles.
Type I and type II strains can be easily distinguished by genetic means
(71) and recently a PCR based test has been developed to discriminate
type II and type III strains (42). However, MAP strains not dependent on
mycobactin and non-MAP mycobacteria containing IS900 have been
identified recently, so new methods of characterisation may be required
(58,80,213).
1.2.2 Transmission of MAP
MAP must be passed from animal to animal within a group in order to
cause paratuberculosis. The experimental infectious dose for MAP is
around 107 to 108 mycobacteria, although the natural infectious dose is
likely to be lower than this (187). It is thought to be spread mainly by the
faecal-oral route via contaminated feed (218,252), as most infected
animals will shed the bacteria in their faeces at some point during the
infection (232). High shedders will, of course, be responsible for higher
rates of transmission (256). As young animals can be readily infected by
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their mothers (8,254), it is accepted that most animals are infected as
neonates by this route. Studies have shown that red deer can be infected
through vertical infection, and are most susceptible to infection below the
age of 8 months (147). Sheep have been implicated in spreading MAP to
cattle on the same farm (163) although the reverse of this may also be
true. However, recent studies have suggested that between herd
transmission of MAP is mainly via the trade in livestock (264). Faecal-
oral spread does not require direct contact with faeces - a recent survey in
Northern Ireland found MAP contamination in 8% of untreated water
samples (271). A second recent study also found that environmental
water samples taken from a dairy were more likely to test positive for
MAP by culture than manure samples taken from a cattle pen (27). This
may, however, be due to lower levels of inhibitors in the water samples.
There are several other proposed routes of infection for MAP. Studies
have suggested that MAP can be transmitted vertically in milk from
apparently healthy mothers, and this route of infection may be common
under normal breeding practises (168). MAP can be cultured from around
2% of milk samples taken from infected herds, 1.6% ofmilk samples
taken from pasteurised retail milk and 3.6% of cheese samples from the
Czech Republic (11,115), although a recent inter-laboratory study has
found that detection rates can vary widely depending on the method used.
PCR methods had the highest sensitivity, and the BACTEC the lowest,
detecting none of the contaminated samples (72). A study into the
persistence ofMAP in cheddar cheese showed that MAP could be cultured
from ripening cheese for up to 27 weeks (73).
MAP can be cultured from the semen of some infected rams and bulls,
leading to the proposal that MAP could be spread during breeding (10,81).
Viable mycobacteria can be isolated from the reproductive organs of
infected animals, and from foetuses of infected cattle (252). However,
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studies in Holstein cattle have suggested that intrauterine transmission
is not an important route of transmission in these animals (155).
There is no evidence of any seasonal effect on MAP transmission (239)
although environmental factors play a part. High rainfall and temperate
climates which encourage higher densities of livestock can lead to higher
rates of transmission. These factors can also lead to annual variations in
transmission rates due, for example, to lower rainfall leading to
clustering of livestock around water sources (l). Soil with a low pH and
calcium and high iron, zinc and manganese content is more likely to
harbour infectious MAP (172). MAP can also be cultured from a range of
environmental nematodes and amoebae, suggesting that ingestion of
these organisms by livestock may aid MAP transmission (192).
Transmission of MAP can occur between livestock species and wild
species which share their habitat — a recent survey in the United States
found only eight different MAP subtypes in thirty-three diverse species of
wild and domestic animals across a wide area of the USA (157). Rabbits
can carry MAP, and tend to share grazing ground with domesticated
animals, allowing contamination of ruminant feed with rabbit faeces
(65,122,259).
1.2.3 Attachment and invasion
How MAP binds to and translocates the intestinal wall is a matter of
much debate and research. The major hypothesis states that binding of
fibronectin by the mycobacteria is key. MAP expresses a fibronectin
attachment protein homologue which mediates the binding of fibronectin
(FN) to the surface of the mycobacteria as it passes through the gut (209).
In vitro, this attachment is optimised by acid pre-treatment, as would
occur in natural infection as the bacteria pass through the stomach. This
bound fibronectin can then bind to integrins on the surface ofM cells in
the follicle-associated epithelium of the Peyer's patches of the ovine gut
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(210). M cells are proposed as the target cell of MAP because they express
integrins on their surface, unlike other cells of the intestinal epithelium
(211,217). The mycobacteria are then internalised by the M cells and
translocate to the basolateral surface of the Peyer's patches. Invasion of
the Peyer's patches is increased 2.6 fold by the binding ofFN (211). This
invasion is rapid, with MAP transversing the intestinal wall and infecting
distal organs within one hour of initial infection (277).
More recent studies have shown, however, that MAP is able to attach to
the intestinal epithelium in areas without Peyer's patches, suggesting
that the mycobacteria can also bind to enterocytes (216). This in turn
suggests that other receptors are necessary, as enterocytes do not express
the integrins required for FN binding. As the ability ofMAP to attach to
the epithelium is consistent no matter which area of the gut is studied,
this further suggests that M cells cannot be the only cell able to bind the
mycobacteria (199). A recent hypothesis suggested that MAP can bind a-
dystroglycan and exploit a host recycling mechanism to allow invasion of
the host cell. This method of invasion is seen in Mycobacteria tuberculosis
invasion of Schwann cells (262), although there is no evidence as yet of
the method playing a role in MAP infection. However, a second study has
shown that MAP can attach to and infect enteric glial cells in culture
(208).
After crossing the intestinal epithelium, MAP is phagocytosed by
intestinal macrophages (218). MAP can be opsonised by the complement
component C3b or antibody at this stage, which greatly increases uptake
by macrophages (110,278). CD11/CD18 seems to be the main receptor
involved in phagocytosis of MAP, although mannose receptors and CD 14
can also be used (226). Once within macrophages, MAP can establish a
persistent infection by preventing acidification of the phagolysosome.
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1.3 Immune response to MAP infection
1.3.1 Macrophage responses
In a typical bacterial infection, the bacteria are phagocytosed by
macrophages, neutrophils or dendritic cells and held in the cell in
phagosomes. This phagocytosis can be mediated by bacterial attachment
to a number of receptors, including Fc receptors that bind to antibodies,
and complement receptors. Phagocytosis via these receptors leads to
macrophage activation. The cellular bacteria lysosomes bind to the
phagosome to form a phagolysosome, which becomes gradually acidified,
leading to bacterial death and digestion. This then leads to bacterial
peptide presentation on the cell surface via MHC class II and activation
of the acquired immune system (181,218).
Once within the macrophage, MAP can prevent the maturation of the
phagosome. In vitro studies have shown that MAP can survive in
phagosomes for several weeks, and in vivo studies have reported finding
intact mycobacteria within ileal macrophages (12,230,252). Compared to
infection with M.smegmatis, a less pathogenic mycobacteria, phagosomes
containing MAP had higher levels of Transferring Receptor, an early
phagosome marker, and lower levels of Lysosome Associated Membrane
Protein 1, a late maturation marker (110). Similarly, a study comparing
MAP infection with Mycobacterium avium found that macrophages were
twice as efficient at killing M.avium as they were at killing MAP (266).
This difference may be mediated by differential activation of the
MAPKp38 pathway (228). This situation is similar in M.tuberculosis
infection, with mycobacteria-containing macrophages displaying a lack of
maturation (54). Although some studies have shown that the bacteria
may be able to grow and multiply within the phagosome, the number of
viable MAP remains constant, suggesting that the macrophage is capable
of killing a limited number of mycobacteria. This killing may depend on
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the multiplicity of infection (MOI) (16,276), and the activation state of the
macrophage (109). A recent study suggested that this survival is due to
the infecting strain of MAP, indicating that some strains may be more
efficient than others at interrupting host immune responses (87).
The mycobacteria prevent bacterial killing through several mechanisms,
including preventing or reducing phagosome and lysosome fusion and
preventing oxygen radical production (230). Studies have shown that
MAP enters the cell via binding to the C3 receptor (181,218). This is
mediated by the association of complement cleavage product C2a. This
can cleave C3, leading to opsonisation of the mycobacteria by C3b and
macrophage recognition (201). This allows the mycobacteria to avoid the
initial anti-microbial activities of the macrophages, as internalisation via
the complement receptors avoids triggering the oxidative burst (181,218).
Mycobacteria are known to recruit a host protein — tryptophan-aspartate
containing coat protein (TACO) - and retain it on their surface. TACO is
a normal component of the phagosome coat that is lost before
acidification, so bacteria retention of TACO prevents phagosome-lysosome
fusion (133,181). Other host genes involved in this lack of phagolysosome
formation include the rab family of GTPases (133) and coronhrl.
Coronin-1 is a leukocyte specific protein, which blocks lysosomal delivery
(119). Two further genes, nucleolin-related protein (NRP) and
nicotinamide adenine dinucleotide dehydrogenase (NADH) were not up-
regulated in macrophage responses to MAP infection, unlike in
macrophages infected with E.coli (247), suggesting these genes may play
a role in phagosome maturation. Mycobacterial genes are also involved
directly in negating the host immune response. MAP has been found to
secrete a tyrosine phophatase upon entry into macrophages, which may
act to dephosphorylate signalling and adaptor molecules (12,227). MAP
can also secrete superoxide dismutase, which can inactivate reactive
oxygen species (218). Interaction ofMAP with TLR2 induces MAPKp38
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signalling and thus an increase in ILrlO expression, reducing anti¬
microbial responses further (229).
This lack of bacterial killing and macrophage activation can prevent the
activation of the acquired immune response. Infected macrophages are
able to produce cytokines, including ILrl, IL-6, IL-12 and TNFa, and
macrophage cultures pre-incubated with IFNy do show increased
bacterial killing (218,227,278). However, infected macrophages do show a
reduction in T-cell activation capacity. This reduction seems to be time
dependent, with normal levels of T-cell activation being observed
immediately after infection, and poor activation being observed one week
after infection (230,278). Infection of monocytes with MAP also leads to
increased levels of apoptosis, although this is not observed in infected
macrophages (4).
1.3.2 Antibody response
Antibodies to MAP are produced early in infection, but never offer
protection. Studies ofMAP infection in cattle have shown antibodies to
two unidentified proteins appearing between 7 and 14 days post infection
(133) and antibodies to lipoarabinomannan (LAM) appearing around 134
days post infection (133,263). Studies using MAP vaccines, again in
cattle, have shown different production times of antibodies, with
antibodies first observed at 56-112 days post infection, peaking at 250
days post infection and undetectable by 420 day post infection (132).
Some studies in sheep have shown antibody detection from 90 days post
infection (136), whereas others have observed a reduction in circulating
IgG upon infection with MAP (23). This early antibody response can be
influenced by several external factors. The age of the animal at infection
or vaccination can have an effect on antibody production and detection. A
study in sheep and goats showed that the size and persistence of the
antibody response to a MAP vaccine is directly related to the age of the
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goats (57). A study in cattle showed that the commercial ELISA test
cannot be used to detect antibody until the animal is over 3 years old
(113). Indeed, in some studies, the ELISA test was not able to detect
antibody responses in cattle shown to be MAP positive through different
tests (263). The infecting strain can also influence antibody production in
sheep. A study comparing five strains found that antibodies were
produced at different levels and at different times in the five groups (260).
Later in infection, antibody levels correlate with bacterial load and
severity of the disease (36), similar to the situation in tuberculosis in
humans (170). In both cattle and deer, there is a strong correlation
between antibody persistence and disease severity (147,174,237).
However, in goats and sheep the association is less straight forward. A
study of MAP challenged goats found only one of three seropositive
animals developed faecal shedding, a sign of disease progression (236). A
similar study in sheep found that no clinically infected sheep developed
an antibody response, despite persistent faecal shedding (235), whereas
other studies have found high levels of antibody production in all
clinically infected sheep (35). This discrepancy seems to be a function of
the different pathologies observed in ovine pathology — studies that group
the sheep by type of pathology found that all animals with multibacillary
disease produce antibodies, whereas only some animals with
paucibacillary disease do (35,136). A recent study has also shown that
sheep can produce autoantibodies in response to MAP heat-shock
proteins, which may lead to complications in these sheep, including anti-
neutrophil cytoplasmic antibodies -associated vasculitis (26).
1.3.3 T cell responses
T cell responses are central to the control of all mycobacterial diseases.
CD4+, CD8+ and y8 T cells are thought to be the main cells involved in
protection, producing IFNy, which can activate macrophages and lead to
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killing of mycobacteria. Antigens presented to CD4+ helper cells are
associated with MHC class II, whereas antigens associated with MHC
class I are presented to CD8+ cytotoxic T cells (218). CD8+ T cells tend to
be associated with anti-viral immune responses and CD4+ T cells are
associated with anti-bacterial and anti-parasitic responses (118). CD4+ T
cells can be classified as Thl or Th2 depending on their function and
cytokine profiles (156). Thl cells produce IFNy and act to promote
mycobacterial killing through the activation of macrophages. Th2 cells
produce IL-4 and ILrlO and act to promote the production of antibodies.
Th2 cells are ineffective against intracellular mycobacteria (131,218).
In tuberculosis infections in humans, CD4+ T cells are critical to control,
and CD8+ T cells contribute to this control by producing IFNy (173,184).
This response can lead to long term immunity and control of infection by
the formation of granulomatous lesions which control bacterial growth
(196). This successful response is a Thl response, characterised by the
production of IFNy (173) and can in some types of tubercular disease
clear the bacteria (17).
The T-cell response in bovine paratuberculosis is largely similar, with
CD4+ Thl cells thought to be central to control through the production of
IFNy (19,242,252), although there is some evidence that in calves, IFNy
production in response to new antigens may be by NK cells, rather than
CD4+ T cells (8). In both human and bovine tuberculosis, NK cells
produce IFNy, increasing macrophage activation and mycobacterial
killing (67,84). In early, sub-clinical MAP infections, y8 T cells are
increased, along with MHC class II expressing B cells (127). This suggests
a role for y8 T cells in the control of MAP infection, although this is still to
be elucidated, as they do not produce IFNy or increase nitric oxide (NO)
production (19,131,219). The number of CD8+ cells in these cattle is
similar to uninfected and clinically infected cattle (127,131). Some studies
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have shown a decrease in the number of CD4+ cells at this stage of
infection (131) whereas others have found that the number of CD4+ cells
does not change (60,127). It seems that early in infection, the IFNy
produced by these CD4+ and CD8+ cells is sufficient to activate
macrophages and control bacterial growth (219). This does not prevent
disease progression, because of a reduction in the ability of infected
macrophages to produce NO and express MHC class II (219,266,267).
Additionally, studies in macrophage cell lines have shown that, although
infected macrophages can produce inflammatory cytokines capable of
activating Thl cells, the second, antigen specific activation step is
inhibited by MAP infection (278). Later in infection, these controlling
CD4+ and CD8+T cells are lost through apoptosis (131) leading to a loss
of macrophage activation and thus an increase in bacterial load (242).
The expression of IFNy is reduced, and Th2 cytokines dominate.
The T cells response in ovine paratuberculosis is initially similar to that
in bovine paratuberculosis. y8 T cells are increased early at the site of
infection (21,23,144), suggesting that these cells may play a role in early
immunological events. CD4+ and CD8+ cells are increased later in
infection (144,186). However, in sheep, the T cell response later in
infection is polarised, and leads to the observed differences in pathology.
Higher numbers of CD4+ and y8 T cells are observed in paucibacillary
lesions, with a corresponding increase in the expression of IL-2 and IFNy
(36,144). Conversely, multibacillary lesions contains fewer CD4+ cells and
an increased number of CD8+ cells, with the related decrease in the
release of proinflammatory cytokines, such as IFNy and TNFa (36,144).
However, in both cases this constitutes a terminal disease state, and
there is no switch from a Thl to a Th2 type response (224).
T regulatory cells (Tregs) have a CD4+CD25+FoxP3+ phenotype, and are
capable of inducing anergy to self and foreign antigens and preventing
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migration of immune cells to the site of infection (273). In both human
tuberculosis and mouse models of tuberculosis, these cells are increased
in number and accumulate at the site of infection. In mice with no Treg
cells, the number ofmycobacteria is reduced compared to wild type mice,
and in mice and humans Tregs can prevent the production of both ILrlO
and IFNy in response to M. tuberculosis infection (46,111,137,203). This
evidence suggests that Treg cells have a vital role to play in tuberculosis
pathogenesis. It is therefore likely, although little is currently known
about Treg cells in paratuberculosis, that these cells are also involved in
the response to paratuberculosis.
1.4 Host gene expression in MAP infection
The profiling of the host gene expression response in MAP infection and
clinical paratuberculosis is ongoing, and reveals much about the immune
response and immune pathways involved in this disease. Most studies so
far have analysed gene expression in cattle, concentrating mainly on
expression in peripheral blood mononuclear cells (PBMCs), using both
microarray and PCR technologies, and several have used non-ruminant
cell lines. One recent study using a murine macrophage cell line described
decreased expression of immunoresponsive gene 1 (IFGl) in MAP infected
cells compared to LPS stimulated cells (18). A second study used a human
monocyte cell line to assess the response to different types of MAP. When
the cells were infected with sheep isolates, up-regulation of several
proinflammatory genes was observed. This up-regulation was not
observed in the cells after infection with cattle or human strains (158)
A series of microarray experiments by Coussens et al have
comprehensively characterised gene expression in bovine PBMCs taken
from MAP infected cattle. PBMCs from clinically infected cows displayed
down-regulation of 83 genes when stimulated with MAP, including
fibroblast growth factor and Lyn B protein kinase. Eight genes were up-
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regulated in these cattle, including CD40L, IFNy and ILrlO. Conversely,
stimulation of PBMCs from sub-clinically infected cattle with Map
induced the up-regulation of 71 genes, including CD40L and several
matrix metalloproteases (MMPs), and the down-regulation of a further 16
genes (61). A second study found that stimulation with MAP was not
needed to produce a difference in gene expression in PBMCs, with 86
genes being differentially expressed in unstimulated PBMCS from
infected cattle compared with similar cells from control cattle (60). A
further experiment showed that stimulation of PBMCs from infected
cattle produced a gene expression response within 4 hours of exposure,
although many of the changes were no longer appreciable by 8 hours post
exposure (62). Further studies to characterise these differentially
expressed genes found that IL-5, GATA 3, TIMPl, TIMP2, IL-10, IFN-y,
TGF6 and ILr8 were up-regulated and MMP14 was down-regulated (59).
Studies carried out by other groups on PBMCs from infected cattle have
identified several more differentially expressed genes. Urocortin , a
neuropeptide of the corticotrophin-releasing hormone family, is up-
regulated (261) and TNFa, RANTES and MCP-1 are down-regulated in
infected bovine PBMCs (37).
A second set of studies into host gene expression in paratuberculosis have
concentrated on differential expression in bovine macrophages. Two
recent microarray studies identified 52 and 47 genes that are
differentially expressed in macrophages from infected cattle compared to
uninfected controls (223,266). Exposure to MAP lead to the up-regulation
of IL-la, IL-10, GM-CSF, IL-18, TNFa andTRAFl, and down-regulation
ofTL-12, IFNy, nucleolin related protein (NRP), nicotinamide dinucleotide
adenine dehydrogenase (NADH) and MHC class I and II genes in bovine
macrophages compared to unexposed controls (48,227,247,267,269).
Similar studies on MAP infected bovine dendritic cells described up-
regulation of CCR7, CCR5, CD40, CD80 and IL-10 and down-regulation
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ofMHC class II genes, IL-12, ILrlB and IL-6 (138,141). A recent study,
however, has shown that the genes differentially expressed in infected
macrophages may depend on the bacterial strain. The study showed
significantly different expression of several genes, including ILrlO, TNFa,
MMP3 and TIMP1, when the expression patterns of cells infected with
sheep and cattle strains were compared (117).
A third group of studies has analysed gene expression in tissues taken
from the ileum of infected cattle. In such tissues, up-regulation of IFNy,
TGF13, IL-5, IL'8, ILrlO, TRAF-1, ILrla, MCP-2, N-cadherin and CD29
and down-regulation of ILrl6 was observed (3,63,128), although this
varied depending on the stage of the disease. Cattle with late,
lepromatous lesions have up-regulated ILr4, ILrlO and IL-2 and down-
regulated IL-18 compared to cattle with early, tuberculoid lesions and
uninfected controls (242).
Far fewer studies have been carried out on the expression profiles of
sheep infected with MAP, perhaps assuming that the profiles would be
similar to those seen in cattle. A study comparing stimulated blood
lymphocytes taken from sheep with both clinical forms of the disease
showed that lymphocytes from multibacillary sheep have down-regulated
IFNy and IL-2 compared to lymphocytes from paucibacillary sheep (36).
Afferent intestinal lymph cells (AILCs) from sheep with clinical
paratuberculosis have decreased IL-4, IL-5 and IL-13 and increased IFNy
and TNFa compared to AILCs from sheep with a parasitic infection (102).
A study on infected ovine ileum found increased TNFa, IL-18 and IL-6
compared to uninfected controls (6). Overall, little is known about gene
expression in ovine paratuberculosis, and there have been no extensive




Crohn's disease (CD) is a chronic inflammatory intestinal disease of
humans, first described in 1932 (44). The symptoms and gross pathology
are similar to Johne's disease in ruminants (222). It can affect any part of
the intestinal tract, and may also affect the liver and pancreas (44). There
are two competing theories as the cause of CD - the first assumes an
autoimmune cause, with no specific infectious agent, leading to an
uncontrolled inflammatory response. The second states that infection
with MAP leads to immune dysregulation and again an uncontrolled
inflammatory response, similar to that seen in ruminant paratuberculosis
(45). In both cases, breakdown of the intestinal barrier and invasion by
gut bacteria are seen as essential to the continuation of the disease (101).
The evidence for the role of MAP in CD is wide ranging and often
contradictory. Many Crohn's disease patients are infected with MAP. Two
studies of Sardinian patients showed that 83-87% were IS900 positive in
blood, compared to 10% of control patients. In addition, MAP could be
cultured from the blood of 63% of CD patients compared to 10% of
controls (197,207). A study in Germany found that 52% of CD tissues
were IS900 positive compared to 5% of controls. The IS900 positive
tissues included small bowel and colon (9). A USA study detected MAP
DNA in the buffy coat fragment of blood from 46% of CD patients,
compared to 20% of controls. MAP could also be cultured from the blood of
50% of CD patients (167). An Indian study detected MAP antibodies in
100% of CD patients compared to 38% of controls (220). A wide ranging
review of such studies concluded that the association of MAP with CD
was specific, but not necessarily causal (83). Although MAP cannot be
visualised in CD tissues by ZN staining, this is thought to be due to the
presence of cell wall deficient bacteria, which do not stain (97,105). MAP
infection can alter the immune response to CD, perhaps worsening the
disease. Increased concentrations of TNFa are found in tissues from MAP
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positive CD patients, compared to CD patients without MAP infection,
non-CD patients with MAP infection and non-infected controls (50).
Transmission ofMAP from ruminants to humans is thought to happen
through the consumption ofmilk and dairy products, or through faecal
contaminated water. A study of dairy farmers found no connection
between contact with dairy cattle infected with MAP and incidence of CD
(120). Viable MAP can be detected by IS900 PCR in raw or pasteurised
milk (11,97), river water destined for domestic water supplies (180) and
commercial cheese samples (51). A recent study found a significant link
between consumption of hand-made cheese and MAP infection in
Sardinia (197). However, an epidemiological study found that
consumption of milk is associated with a reduced risk of CD, and that
there was no link between consumption of contaminated water and CD
(2).
Susceptibility to CD is associated with polymorphisms in the
NOD2/CARD15 and NRAMP1 genes (74,205). Susceptibility to MAP in
cattle is also associated with polymorphism in these genes, suggesting a
common disease pathway (182,193). However, in CD an association could
not be found between NOD2/CARD15 mutations and MAP infection (28).
These observations have lead to suggestions that anti-MAP therapy could
be an efficient treatment for CD. However, a recent study of the efficacy
of combined anti-microbial agents in the treatment of CD did not find any
long-term benefit (212). Sulfasalazine is commonly used as an anti¬
inflammatory drug to treat CD, and has recently been shown to inhibit
MAP growth in culture, leading to the study author suggesting that the




Taking all of this evidence together, a recent epidemiological study
concluded that four of six epidemiological causal criteria (strength of
association, consistency of effect, temporality and biological plausibility)
were satisfied and thus that the evidence strongly supports the causal
relationship between MAP and CD (251).
1.6 Aims and objectives
This study tested the hypothesis that expression of immuno-
inflammatory genes differs in the three forms of paratuberculosis.
This PhD had four major aims>
• To define comprehensively the three types of pathology, through
gross pathology, histopathology and molecular approaches, in order
to provide robust definitions for the rest of the study.
• To quantify expression of specific cytokine genes in order to
confirm the polarisation of the immune response in sheep with the
two clinical forms of the disease, and to explore the cytokine
responses in asymptomatic sheep.
• To quantify the expression of a range of immunoinflammatory
genes using microarray technology to produce a comprehensive
molecular signature of the different pathologies.
• To explore the presence of SNPs in genes found to be differentially
expressed in the two clinical forms of the disease, in order to assess
whether genetic changes are responsible for the observed
differences.
The results of the studies provide a robust molecular definition of the
forms of ovine paratuberculosis, and provide a framework for further
analysis of the pathways involved in immune response to this disease.
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2.1 Experimental animals and disease diagnosis
2.1.1 Experimental animals
Animals with and without clinical paratuberculosis were out bred sheep
from one of three farms. Sheep suffering from wasting, loss of condition
and diarrhoea were delivered to the Moredun Research Institute (MRI)
suspected of having of paratuberculosis. Thirty infected sheep were used
- ten multibacillary, ten paucibacillary and ten asymptomatic. All sheep
were euthanized at MRI and ileum and lymph node tissue and blood
samples taken. Faecal samples were taken and faecal egg counts made
(Table 2.1). All experimental procedures involving animals were
performed under licence as required by the UK Animals (Scientific
Procedures) Act 1986. Control sheep were from a flock that had never had
a clinical case of paratuberculosis (n=9).
2.1.2 Diagnosis of paratuberculosis and definition of pathological forms
All experimental animals were diagnosed on the basis of histopathology of
the terminal ileum and IS900 real-time RT-PCR. The age, sex and breed
of these sheep are given in Table 2.1. Terminal ileum samples for
histopathology were fixed in 10% formal-saline. Sections 4pm thick were
cut from paraffin wax-embedded tissue and stained with haematoxylin
and eosin (H&E) (143) or Ziehl'Neelsen (ZN) (126).
Ileum derived RNA samples from all experimental sheep and mesenteric
lymph node RNA samples from asymptomatic sheep were tested for the
presence of MAP by real-time RT-PCR for IS900, a MAP specific insertion
sequence (29,232). Primers and probes were designed by Eishi et al (76),
and the reactions were carried out in an ABI prism 7000 real-time PCR
machine. Each reaction contained 12.5pl Platinum® Quantitative PCR
SuperMix-UDG with ROX (Invitrogen), 50nM each primer, lOOnM probe
and 5pl cDNA, generated from 2.5pg RNA, made up to 25pl with
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deionised water. The reactions were cycled as follows: 50°C for 2 minutes,
95°C for 10 minutes and 40 cycles of 95°C for 15 seconds, then 60°C for 1
minute. (Addresses of all suppliers listed in appendix l).
A commercial antibody ELISA (Institut Pourquier) was used to detect the
level of MAP specific antibody in the blood of the experimental animals.
This ELISA has a sensitivity of 34.9% and a specificity of 98.8% in sheep
(98). The assays were carried out by Biobest Laboratories Ltd. Briefly,
the ELISA tested for antibodies towards a protoplasmic extract of MAP.
Each sample was tested in duplicate. The results were expressed as a
percentage of the reaction in a standardised positive control. A result of
less than 60% was considered to be negative, a result of 60-70% was
considered doubtful and repeated, and a result of more than 70% was
considered positive.
2.2 Tissue selection and removal
Terminal ileum tissue was chosen, as this area of the intestine is known
to be the main focus of pathology in MAP infection (211,218).
Approximately 0.5g of ileum tissue was removed post-mortem, placed in
five volumes of RNA/afer™ (Ambion) and left overnight at 4°C. The ends
were then trimmed and the tissue archived at "80°C.
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Table 2.1: Breed, age, sex and FEC of experimental sheep
Sample Breed Age (years) Sex FEC* Type of Infection
3 Blackface X Bleu du Maine 4.5 F - Paucibacillary
4 Texel 5.5 F 225 Paucibacillary
Blackface x Bleu du Maine X
2.5 252 Paucibacillary5 Lleyn x Roussin
F
6 Lleyn X Roussin 3.5 F 36 Paucibacillary
7 Bleu du Maine 4 F 423 Paucibacillary
8 Blackface x Bleu du Maine 6 F 180 Paucibacillary
9 Texel 2.5 F 378 Paucibacillary
10 Blackface 2.5 F 0 Paucibacillary
32 Blackface X Bleu du Maine 4.5 F 252 Paucibacillary
34 Blackface X Bleu du Maine 4.5 F 117 Paucibacillary
11 Blackface 3 F 2171 Multibacillary
12 Blackface 2 F 1188 Multibacillary
13 Blackface 4 F 5058 Multibacillary
14 Blackface 4 F 3210 Multibacillary
16 Blackface 3 F 2358 Multibacillary
17 Blackface 3 F - Multibacillary
27 Blackface 5 F 2124 Multibacillary
28 Blackface 5 F 3150 Multibacillary
29 Blackface X Bleu du Maine 4.5 F - Multibacillary
30 Blackface X Bleu du Maine 4.5 F - Multibacillary
19 Blackface X Bleu du Maine 7 F 189 Asymptomatic
20 Blackface X Bleu du Maine 7 F 1116 Asymptomatic
21 Greyface 2-4 F 3 Asymptomatic
22 Greyface 2-4 F 108 Asymptomatic
23 Texel 1 F 13 Asymptomatic
24 Blackface 2.5 F 1731 Asymptomatic
25 Greyface 2-4 F 4 Asymptomatic
26 Greyface 2-4 F 1197 Asymptomatic
31 Blackface X Bleu du Maine 4.5 F 1305 Asymptomatic
33 Blackface X Bleu du Maine 4.5 F 135 Asymptomatic
*There were no statistically significant differences in FEC between the three groups of
samples.
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2.3 Isolation of RNA from Ileum tissue
2.3.1 Homogenisation of tissues
Tissue samples were removed from -80°C storage and thawed on the
bench. 250mg was weighed out into a sterile Petri dish, and chopped into
small pieces using a sterile scalpel. Shredded tissue was placed in a
sterile Lysing Matrix D ribolyser tube (Q-Biogene) containing 1.4mm
ceramic spheres. This tissue was disrupted and homogenised in lysis
buffer containing guanidine isothiocyanate (RNeasy from Qiagen) using a
ribolyser and then spun at 13,000xg for ten minutes to pellet the cell
debris. Lysate was removed and placed in a sterile 15ml Falcon™ tube
(BD Biosciences). A second aliquot of buffer was added to the ribolyser
tube, and the homogenisation was repeated to maximise RNA
concentration. The second aliquot was added to the Falcon™ tube, and
the total volume made up to 15ml with the lysis buffer.
2.3.2 RNA extraction from tissues
The lysate was centrifuged for 10 minutes at room temperature, and then
the supernatant placed in an RNeasy Maxi column, taken from the
Qiagen RNeasy® Maxi Kit. Further steps were carried out according to
manufacturer's instructions. The RNA was eluted into 0.8ml of RNase-
free water. The RNA was concentrated by ethanol precipitation and
resuspended in 0.3ml of RNase-free water. The samples were DNase
treated using the Ambion DNase I kit, according to manufacturer's
instructions. Samples were checked for genomic DNA contamination by
the presence or absence of a GAPDH PCR product (For primers see Table
2.2).
2.3.3 Measurement of RNA/DNA concentration
The concentration of nucleic acid in a sample is directly proportional to
the absorption of UV radiation at 260nm by the sample. The
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concentration of nucleic acid in a sample was determined by
spectrophotometry. The absorbance was measured at 260nm and 280nm.
The ratio of these absorbances was used as a measure of the quality of the
sample — a ratio of 2:1 was considered optimal.
RNA concentration = A260 x 40 x dilution factor
DNA concentration = A260 x 50 x dilution factor
The RNA samples were also quantified using an Agilent Bioanalyser
2100, which uses LabOnChip technology to determine RNA quantity and
quality. The RNA integrity number (RIN) is a value provided by the
Agilent Bioanalyser software (2100 expert), giving a measure of RNA
fragmentation - samples with a RIN of less than 6 were excluded from
the experiment (202). RIN values were not available for samples 29-34 or
the control samples as they were analysed on an earlier version of the
Agilent Bioanalyser software. These samples had previously been used
successfully in real-time RT-PCR and were therefore judged to be of
sufficient quality. RNA of control sheep was kindly provided by Dr K.
Nalubamba.
2.4 Reverse transcriptase-polymerase chain reaction
2.4.1 Reverse transcription of RNA into cDNA
2.5pg ofRNA was suspended in a final volume of 16.25pl in nuclease free
water, giving a final RNA concentration ofO.lpg/pl. 500ng ofOligo(dT)
(Promega) was added, and incubated for five minutes at 70°C, followed by
five minutes on ice. To this 5pl of 5x MMLV buffer, 1.25pl of lOOmM
dNTPs and lpl of MMLV RT enzyme (Promega) were added, and the
mixture was incubated at 42°C for 60 minutes, followed by 15 minutes at
70°C to inactivate the enzyme.
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2.4.2 Primer design
Primer sequences and accession numbers are given in Table 2.2. Primer
sets marked with * were kindly provided by other members of the
research group. Primers were designed for the rest of the genes of interest
using published ovine or bovine sequences with Primer3
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and NetPrimer
(http://www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html)
software. Ideally, primers would have a GC content of between 40-60%;
be 18 to 25 bases long! produce a fragment of between 100"250bp in
length and have minimal secondary structure and self-complementarity.
Primers were designed to be as close to this ideal as possible.
2.4.3 Amplification
Amplification was carried out in a Hybaid Sprint Thermocycler, in a final
volume of 50pl. 2pl of cDNA synthesised from 2.5pg of RNA was added to
the following reagents: 5pl of lOx ThgDNA Polymerase buffer (Promega);
dNTPs to a final concentration of 800pM; forward and reverse primers to
a final concentration of 500pM; and 1.25U of Tag DNA Polymerase
(Promega), made up to 50 pi with nuclease free water. Optimisation of
annealing temperature for each primer set was carried out. The reactions











*The annealing temperature was optimised for individual primer sets
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2.5 Agarose gel electrophoresis
2.5.1 Preparation of agarose gels
Agarose gels were prepared at different concentrations depending on the
size of the DNA fragments to be visualised. PCR products were visualised
on a 2% agarose gel, linearised plasmids were visualised on a 1% agarose
gel. Gels were prepared by adding the correct weight of agarose (Qualex
Gold Agarose, Thermo-Hybaid) to lx Bionic buffer (Sigma) and heating
until the agarose was fully dissolved. This was then cooled, and lpl of
lOmM ethidium bromide or lpl/ml GelRed nucleic acid gel stain
(Cambridge Bioscience Ltd) was added. The gel was poured into a tray
and allowed to set.
2.5.2 Running agarose gels
The gel was submerged in lx Bionic buffer. Samples were mixed with 6x
loading dye (Promega) and loaded into wells. 1Kb and lOObp DNA ladders
(Promega) were used. Electrophoresis was carried out at a constant 150V
until sufficient DNA separation was achieved. Gels were examined in an
ultraviolet transilluminator (Ultraviolet Products) and captured using
Labworks™ software.
2.6 Cloning of the PCR product
2.6.1 Ligation into pGEM®-T easy vector
PCR products were purified using the Qiagen QIAquick PCR purification
kit according to manufacturer's instructions. The PCR products were
eluted into 50pl of EB (lOmM Tris CI, pH 8.5). 3pl of the PCR product
was ligated into the pGEM®-T easy vector (Promega) according to
manufacturer's instructions.
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2.6.2 Transformation into JM109 cells
The ligated pGEM®-T easy vector reactions were transformed into 20pl of
JM109 High Efficiency Competent cells, according to the Promega
pGEM®-T easy vector protocol. The cells were plated onto
Amp/XGAL/IPTG plates to allow blue/white selection of colonies. Only
white colonies contained the vector and insert.
2.6.3 Plasmid DNA purification
An overnight culture of bacteria picked from white colonies on the agar
plates was lysed and spun to pellet the insoluble fraction. The
supernatant was then applied to a QIAprep column. The pDNA from
cloned JM109 cells containing the Promega pGEM®-T easy vector was
purified using the Qiagen QIAprep spin miniprep kit, following the
manufacturer's instructions and the concentration determined.
2.6.4 Restriction enzyme digest
To check the size of the insert, pDNA was digested using EcoRI
restriction enzyme (New England Biolabs). 500ng - lpg ofDNA was
diluted to a final volume of 17pl in nuclease free water. 2pl of lOx EcoRI
buffer and lpl of EcoRIenzyme were added, and the reaction incubated
at 37°C for two hours. The insert was separated on a 2% agarose gel.
2.7 DNA sequencing
DNA sequencing was carried out according to instructions received from
Zoology Sequencing Stores, Oxford, lpl of template DNA was mixed with
0.5pl BigDye, 1.75pl 5x sequencing buffer, 3.2pl of lpM T7 or Sp6 primer
and 3.55pl nuclease free water. The reaction mixtures were cycled in
Hybaid Sprint Thermocycler as follows^
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5 seconds >■ 30 cycles
2 minutes.
The DNA was ethanol precipitated and excess ethanol removed by drying
under a vacuum. The reactions were sent to Zoology Sequencing Stores,
Oxford for sequencing.
2.8 Real-time reverse-transcriptase polymerase chain reaction
2.8.1 Overview
Briefly, samples were reversed transcribed and run in real-time RT-PCR
alongside a standard curve of known template concentration. Comparison
with the standard curve allowed absolute quantitation of the copy
number of a gene of interest, and thus allowed the levels of mRNA of
genes in different samples to be compared.
2.8.2 Linearization of plasmids
Purified pDNA was linearised using either Ncolor AT/e/restriction
enzymes (New England Biolabs). lpg of pDNA was diluted in nuclease
free water to a total volume of 17pl. 2pl of lOx buffer and lpl of the
restriction enzyme were added, and the reaction mixture incubated
overnight at 37°C. A 2pl aliquot of the linearised plasmid was run on a
1% agarose gel to check the linearization was complete.
2.8.3 Generation of standard curves from cloned pDNA template
Linearised plasmid DNA was purified using a Qiagen MinElute PCR
purification kit and eluted into lOpl of EB. The concentration of each
cloned pDNA was then determined. A one in ten serial dilution (10"1 to 10"
10) of the linearised plasmid was produced and used to construct a
standard curve in a Rotorgene 6™ real-time PCR machine (Corbett Life
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Science). Duplicates of 2pl of each dilution were run along with a negative
control (nuclease free water), and a positive control (cDNA generated
from ileum derived RNA).
A melt curve was run for each standard curve. SYBR Green binds to any
double stranded DNA in the sample, and thus if primer-dimers are
produced this can affect the reported concentration of the gene of interest.
The melt curve contains a peak for every different size of DNA fragment
produced during the amplification. A good amplification should have one
peak in the melt curve, whereas an amplification containing primer-
dimers has two or more peaks. Therefore using a melt curve allowed runs
where primer-dimers were present to be excluded.
2.8.4 Reaction mix and cycling conditions
For each real-time RT- PCR reaction, 2pl of template cDNA were added to
18pl of reaction mix. The mix contained 2pl of lOx buffer, 200pM of
dNTPs, 250nM of each primer, MgCh to an optimum concentration, 0.7pl
of a 1/1000 dilution of SYBR green master mix and 0.75U FastStart Taq
DNA Polymerase (Roche), made up to a final volume of 18pl with






Melt curve; 65°C rising to 94°C at 0.3°C per second
*For all genes except CD34 which was 57°C
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2.8.5 Variability assay
To determine the level of variability inherent in the real-time RT-PCR
reactions, a variability assay was carried out. A single sample was
reverse transcribed in three simultaneous reactions. The cDNA produced
was then amplified ten times each in an SDHA real-time PCR reaction.
The resulting copy numbers were then compared to give a value for the
variability inherent within the reactions (Table 2.3).












1 349,426 256,928 299,159 1.4
2 335,181 214,713 289,186 1.6
3 240,399 161,965 195,420 1.5
Mean 308,335 211202 256,655 1.5
Range 349,426 161,965 - 2.2
The overall inherent variability of the assay was 2.2 fold. This was taken
as the threshold value for the analysis of the genes of interest.
2.8.6 Real-time RT-PCR for genes of interest
Genes of interest for the real-time RT-PCR analysis were selected from
published sources and preliminary microarray data. RNA was extracted
from ileum samples and reverse transcribed. The cDNA was diluted 1-4 in
nuclease free water. GAPDH PCR was run on each sample to make sure
that amplifiable material was present. 2pl of each sample was run in
triplicate against both the gene of interest and a reference gene. Each run
included five dilutions from the standard curve and a negative control
(nuclease free water) for both the gene of interest and the reference gene.
Four assays were run for each gene, each containing a different group of
samples (paucibacillary, multibacillary, asymptomatic or control).
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2.8.7 Normalisation of real-time data
The copy number of each gene of interest was normalised to allow for
variation in the starting material and technical error. Copy numbers of
reference genes were divided by the 75th percentile of the reference gene
copy numbers and then the mean was calculated to give the
normalisation coefficient. Each value for copy number of the gene of
interest was then divided by the normalisation coefficient. The mean of
the three values of copy number for each sample was given as the overall
copy number for that sample. An example is given in Table 2.4.
Table 2.4: Example of normalisation, taking into account the 75th percentile
SDHA copy Normalisation IL-10 copy Normalised IL-10
Sample number coefficient number copy number
1 5 1.05 10 8.3
6 7
4 9
2 6 0.98 10 10.2
4 11
4 9
3 2 0.56 4 7.1
3 3
3 5
Samples with a normalisation coefficient of less than 0.45 or greater than
2.2 were excluded from the analysis, as this was outside the acceptable
level of variation of the assay (see 2.8.5).
2.9 SNP analysis of CXCR4 and IGFBP-6
2.9.1 Overview
From the results of the real-time RT-PCR analysis the two candidate
genes that demonstrated differential expression between paucibacillary
and multibacillary samples - CXCR4 and IGFBP-6 - were chosen to be
further studied using single nucleotide polymorphism (SNP) analysis.
Briefly, primers were designed to amplify the coding regions of these
genes. These regions were then cloned and sequenced in all
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multibacillary, paucibacillary and asymptomatic samples, and compared
to identify SNPs.
2.9.2 Genomic DNA extraction from tissues
Genomic DNA was extracted from ileum samples from all paucibacillary,
multibacillary and asymptomatic sheep of interest using either the
Qiagen DNEasy Blood and Tissue kit or the Qbiogene FastDNA kit
according to manufacturer's instruction. Using the DNeasy Kit, 25mg of
RNAZafcr™ treated ileum tissue was thawed and cut up into small
pieces. The tissue placed in a salt buffer containing proteinase K and
incubated at 56°C until the tissue was fully lysed. The samples were then
RNase A treated and the pH adjusted using buffers supplied in the kit.
This mixture was placed into a DNeasy mini spin column and spun to
bind the DNA to the membrane. The column was washed twice and the
DNA eluted into 200pl ofAE buffer. Using the FastDNA kit, 25mg of
RNA/ater™ treated ileum tissue was placed in a tube containing garnet
beads and a XA inch ceramic sphere, along with a specific tissue cell lysis
buffer. This was homogenised in a FastPrep instrument until the tissue
was fully lysed, and centrifuged to collect the cell debris. The supernatant
was placed in a fresh tube with a DNA binding matrix. The sample was
then spun again to pellet the binding matrix, and the supernatant
removed. The binding matrix was washed and re-suspended in lOOpl
DES. The sample was again spun, and the supernatant containing the
genomic DNA removed and placed in a fresh tube.
After extraction, all samples were quantified in the Nanodrop 1000
spectrometer (Nanodrop Technologies).
2.9.3 Primer design
Full length mRNA sequence was obtained for both genes, and aligned to
bovine genomic sequence to identify the coding regions for both genes in
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the genomic sequence. Primers were then designed as described in section
2.4.3 to amplify the whole coding region and the intron / exon boundaries
where possible. The primers are given in Table 2.5 below.
2.9.4 Cloning and sequencing of gene fragments
Three PCR reactions using each set of primers were carried out on all
paucibacillary, multibacillary and asymptomatic samples. The PCR
products were mixed, purified, ligated, cloned into the PGEM-T easy
vector as described in section 2.6 and sequenced as described in section
2.7. Three minipreps of each of the amplified fragments, giving three
independent sequences, were produced for each sample.
2.9.5 SNP analysis of sequences
Three clones of each gene fragment were sequenced in the forward
direction for each sample. All sequences were first checked to ensure that
they contained the intended insert — those that did not were discarded.
The three correct sequences were entered into VectorNTI AlignX software
and aligned to produce a consensus sequence for each sample. The
consensus sequences were then aligned. Differences between the genomic
sequences were considered to be SNPs when the same change was found
consistently in two or more of the consensus sequences.
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F1-GAAACTTCAGTGTGTTGGCT52.23186 R1-CCACTCAGAGAGGCGGTTG53.78 F2-ATTCCCTTGCCTGTTTTTCA57.3561 R2-GTACCTCTCATCCACCTCCTTG57.78 F3-GTCTGGCTACCTGCTGTCCT56.5736 R3-GAATGTCCACCTCGCTTGC58.50 F4-CCCATCCTCTATGCCTTCCT58.17398 R4-CGGTCCTACAATGACACACAGC60.36 F5-GAATCTTCAAGTTTTCACTCCAG55.593 R5-GCCAAAGGAATGCCAATAG55.75 F1-CTGGGAAGGGAGGAGGTAGAG59.47456 R1-CGCAGTTGGGAGTGTAGACC57.78 F2-CTTGCGGCTGTAGGAGAGAATC60.9255 R2-CAGGACTGGGATGGGAGACTT60. 3 F3-AAGTCTCCCATCCCAGTCCT60. 1296 R3-GAAGGGCAGCGTCTCATTTA60. 5 F4-GAGGTCCTTGCTGGTGTG53.25306 R4-GAACACAGAGACATAAACCAGAG53.53
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2.10 Microarray Analysis
2.10.1 Overview
Briefly, six RNA samples of each type were reverse-transcribed in the
presence of amino allyl dUTP to produce amino allyl modified cDNA. A
fluorescent dye was then chemically coupled to the modified cDNA. Two
samples, labelled with either red (Cy5) or green (Cy3) fluorescent dyes,
were then mixed and hybridised to a RIGUA Microarray slide in a
competitive hybridisation assay. The slides were then scanned and the
relative intensities of each dye calculated. This was then used to compare
the relative concentrations of specific mRNA in each sample, and thus
compare gene expression under different conditions.
2.10.2 cDNA generation
cDNA generation was carried out using the Fairplay III Microarray
Labelling Kit (Stratagene) according to manufacturer's protocol. lOpg of
total RNA was re-suspended in 12pl diethylpyrocarbonate (DEPC)
treated water, lpl of 500ng/pl oligonucleotide d(T)i2-i8 primer was added
to the RNA and the sample was incubated at 70°C for ten minutes and
cooled on ice. 2pl of lOx AffinityScript RT buffer; lpl of 20x dNTP mix;
1.5pl of 0.1M dithiothreitol (DTT); 0.5pl of RNase block and 3pl
AffinityScript reverse transcriptase were then added to the sample. The
sample was incubated at 42°C for 60 minutes. lOpl of 1M sodium
hydroxide was added to hydrolyze the RNA and the mix heated to 70°C
for 10 minutes. The sample was then cooled to room temperature and
lOpl of 1M hydrochloric acid added to neutralize the reaction.
2.10.3 cDNA purification
cDNA was purified following the RT reaction to remove unincorporated
nucleotides and hydrolyzed RNA, which may interfere with the cDNA
labeling and hybridisation steps. 4pl of 3M sodium acetate; lpl 20mg/ml
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glycogen and lOOpl of 95% ethanol were added to the sample. The
samples were then placed at -20°C for up to two months.
After storage at -20°C, samples were placed in a centrifuge and spun at
13500xg for 15 minutes at 4°C. The supernatant was removed from the
samples and the resultant pellet washed with 500pl ice-cold 70% ethanol.
The samples were spun at 13500xg for 15 minutes at 4°C, the
supernatant removed and the pellet dried.
2.10.4 cDNA dye-coupling reaction
Before the cDNA dye-coupling reaction, one vial of either Cy3 or Cy5
mono-reactive dye (GE Healthcare) was resuspended in 45pl ofDMSO.
The purified cDNA pellet was then re-suspended in 5pl of 2x coupling
buffer (supplied with Fairplay III kit). To the resuspended cDNA 5pl of
either Cy3 or Cy5 dye was added, and the sample incubated for 30
minutes in the dark at room temperature.
2.10.5 Dye-coupled cDNA purification
The DyeEx spin 2.0 kit (Qiagen) was used to remove unincorporated dye
from the labelled cDNA according to the manufacturer's instructions.
Briefly, a column containing hydrated gel-filtration resin was spun to
remove excess liquid. The dye-coupling reactions were then placed onto
the top of the column. The column was centrifuged at 2100rpm for three
minutes. The eluate from the column containing the purified labelled
cDNA was retained.
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2.10.6 Analysis of fluorescence labelled cDNA
Labelled cDNA was analysed using a Nanodrop 1000 instrument. The
absorbance spectrum at 240"800nM was collected and the concentration
of dye in each sample calculated using the Beer-Lambert Equation
(Absorbance = extinction co-efficient x path length x concentration) as
follows:-
Cy3 concentration = A550 / (150000 x path length)
Cy5 concentration = A650 / (250000 x path length)
Concentrations were calculated by the Nanodrop 1000 software and
expressed as pmol/pl of dye.
2.10.7 Pre-soak and pre-hybridisation of microarray slides
Pre-hybridisation treatment, hybridisation and post-hybridisation washes
of the microarray slides were carried out using the Pronto!™Universal
Hybridisation Kit (Corning). Before commencing pre-hybridisation
treatment, wash solutions were prepared using kit reagents as follows: -
Wash solution L 447.5ml of water
50ml of wash reagent A
2.5ml of wash reagent B
Wash solution 2'- 1425ml ofwater
75ml of wash reagent A
Wash solution 3: 300ml of wash solution 2
1200ml ofwater
The slides were first placed in pre-heated (42°C) pre-soak solution
containing a L100 dilution of liquid borohydride and incubated at 42°C
for 20 minutes. They were washed twice for thirty seconds in wash
solution 2, and then immersed in pre-heated (42°C) pre-hybridisation
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solution for 15 minutes. The slides were then washed once in wash
solution 2 for 60 seconds, twice in wash solution 3 for 30 seconds and once
in nuclease-free water for 30 seconds. The slides were then dried by
centrifugation at 1600 x g for two minutes.
2.10.8 Microarray hybridisation
Prepared Microarray slides were placed in the hybridisation chambers of
a Slidebooster™ hybridisation station (Implen). A coupling buffer
(Advason™, Implen) was placed between the slide and the agitation chips
on the slide booster to improve sample agitation, and a humidifying
buffer (Advahum™, Implen) was pipetted into the wells in the
slidebooster to prevent sample drying. A 22x22mm lifterslip (VWR) was
then placed over the array and the slide pre-heated to 42°C.
Equal dye concentrations from two samples coupled with each dye were
mixed and dried. The samples were re-suspended in 20pl cDNA
hybridisation solution and incubated at 95°C for two minutes and then
centrifuged at 13500 x g for two minutes. The samples were introduced to
the array by pipetting the solution under one corner of the lifter slip and
allowing the solution to spread over the array by capillary action. The
hybridisation chamber was then closed and the slide incubated for 16"20
hours at 42°C with agitation every 7 seconds.
2.10.9 Post-hybridisation treatment
After hybridisation, the slides were removed from the hybridisation
chambers and the lifter slip removed by rinsing with pre-heated (42°C)
wash solution 1. The slides were then immersed in wash solution 1 at
42°C for 5 minutes. They were removed from wash solution 1, placed into
an Advawash™ (Implen) slide washing station and washed five times for
two minutes in wash solution 2, and three times for 3 minutes in wash
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solution 3. The slides were dried by centrifugation at 1600rpm for 2
minutes.
2.10.10 Microarray slide scanning
The slides were scanned in an Axon Autoloader 4200AL scanner
(Molecular Devices), controlled by Genepix Pro software. A preliminary
scan was done to automatically set the photo multiplier tube (PMT) gain,
followed by a data scan at a resolution of lOnm. Images were saved as .tiff
files.
2.10.11 Bluefuse analysis of microarray results
Images obtained in Genepix were loaded into Bluefuse™ software version
3.3 (BlueGnome Ltd). The Cy5 images were set to channel one (CHl), and
the Cy3 images set to channel two (CH2). Bluefuse software was then
used to align a GAL file with the image. The GAL file contains
information on the position and identity of each spot on the array, and is
used by Bluefuse to align a grid with the image. The image was then
quantified. Integral to this program is the subtraction of background
noise and the quantification of the intensity of each channel for each spot,
producing ratios of the two channels. Each quantified spot was then
examined visually for spots that were smeared or disrupted by dust
particles. These were deemed invalid and were manually excluded from
further analysis. Quality control checks were carried out on each array by
examining heat plots of spot intensity, graphs of channel one amplitude
versus channel two amplitude, average log intensity versus log ratio (MA
plot) and box plots of inter array variation. Heat plots of spot intensity
were quantified by calculating the correlation of the intensity of one spot
and that of its four neighbours. This is expressed as an R value, where
acceptable arrays have an R value of <0.4 (188).
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2.10.12 Bioconductor normalisation of microarray data
Data generated by Bluefuse was entered into Bioconductor, an open
source statistical package using R programming language and limma
(linear models for microarray data) packages. All Bioconductor-based
analysis was carried out by Mrs Jill Sales (Senior Statistician,
Bioinformatics and Statistics Scotland). Normalisation was carried out
using a weighted print-tip Loess method. Briefly, microarray
normalisation involves the assumption that there should be no difference
in the expression of most genes, thus the expected MA plot is horizontal
and centred on zero. Print tip loess fits a linear regression model to each
subgrid on the array, and adjusts this to fit the expected curve. Spots
were weighted by the confidence given in BluefuseJ in addition the blanks
(unknown), buffer spots and Calf Thymus DNA were given a weight of
zero and hence were ignored in the normalisation process. Manually
excluded spots had been assigned a confidence of zero in the data files so
these were also automatically ignored. Although spot weights were used
in the normalisation, no spots were removed from the data set so
normalised values were available for all spots, including those that had
been assigned a weight of zero. To combine the data from all replicates,
the software averaged the estimates over the sets. P values were
calculated by a t-test, and adjusted to account for the false discovery rate,
as described by Benjamini and Hochberg (25).
2.10.13 Data filtering
The raw normalised data was filtered first by fold-change, discarding
data with a fold-change of less than 1.5. The remaining data was then
filtered by statistical significance, discarding data with an adjusted p
value greater than 0.05. Next, data for the two independent oligos for
each gene were compared, and where the trends for each oligo disagreed,
the data was discarded. Finally, an average fold-change across of the
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oligos for each gene was calculated, and a list of significantly different
genes produced.
2.10.14 Pathway Analysis
The gene list generated as described in section 2.10.13 was first altered so
all of the gene names were consistent with HUGO gene nomenclature
committee names (www.genenames.org). The gene list was then entered
into freely available bioinformatics software
(http://david.abcc.ncifcrf.gov/home.jsp) and pathways of interest
identified. These pathways were visualised using KEGG pathways
(http://www.genome.ad.jp/kegg/pathway.html) and Biocarta pathways
(http://www.biocarta.com/index.asp).
2.11 Real-time RT-PCR validation of microarray results
2.11.1 Reverse transcription of RNA into cDNA
All RNA samples were diluted to a final concentration of lOOpg/pl in
nuclease free water. 5pl of each RNA sample was mixed with 1 lpl
nuclease free water, 500ng of Oligo(dT) and lpl of lOOmM dNTPs
(Promega) and incubated for 5 minutes at 70°C, followed by 5 minutes on
ice. To this 5pl of 5x First Strand buffer, lpl 0.1M DTT and lpl of
Superscript™ III RT enzyme (Invitrogen) were added, and the mixture
was incubated at 50°C for 30 minutes, followed by 15 minutes at 70°C to
inactivate the enzyme. This was done in triplicate for all RNA samples.
GAPDH real-time RT-PCR was run on each sample to make sure that
amplifiable material was present.
2.11.2 Primer design and cloning
Primers were designed and the fragments cloned as described in section
2.4.3. The primers are shown in Table 2.6 below.
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2.11.3 Primer optimisation and generation of standard curves
Primers were optimised for annealing temperature and primer
concentration using a standard curve generated from linearised pDNA as
described in section 2.7. All serial dilutions were generated by the CAS-
1200 automated PCR setup machine (Corbett Robotics). Standard curves
used to determine the efficiency of the PCR assays were generated from
serial dilutions of a pool of all cDNA samples. These standard curves were
also used to determine the optimum cDNA concentration for the assays.
2.11.4 Selection of reference genes
Reference genes were selected using GeNorm software. Briefly, a panel of
reference genes were assayed against all of the samples in real-time RT-
PCR, and the results entered into the GeNorm software. A list of these
genes and their primers are given in Table 2.7. The software determined
which gene was the most stably expressed in the given sample set by
taking account of the average pairwise variation. The two most stably
expressed genes, SDHA and YWHAZ, were chosen to normalise the real¬
time RT-PCR assays.
2.11.5 Reaction mix and cycling conditions
All real-time PCR reactions were set-up by the CAS-1200 machine. 4pl of
cDNA at the optimum dilution was added to a mix containing 5pl 2x
FastStart SYBR Green Master mix (Roche) and 0.5pl of each primer at






20 seconds f 45 cycles
20 seconds „
Melt curve: 65°C rising to 94°C at 0.3°C per second
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2.11.6 Real-time RT-PCR for genes of interest
Each run assayed one gene of interest and contained all samples in
duplicate, a cDNA standard curve and a non-template control. This was
then repeated twice using a cDNA from the second and third RT
reactions.
2.11.7 Normalisation of real-time PCR results
The real-time data was normalised using QBase software (103). The
software first calculated the average Ct value for each sample and then
converted this into relative quantities, taking account of the efficiency of
the reaction, using a pre-determined calibrator sample — for most
comparisons this was one of the control samples. The reference genes
were then used to calculate a normalisation factor as per Vandesompele
et al2002 (257). The relative quantities were then divided by the
normalisation factor to give normalised relative quantities. A 2-sample t-
test was then performed on each of the six comparisons.
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CHAPTER 3 DEFINITION OF PATHOLOGICAL FORMS
Chapter 3: Definition of pathological forms of
paratuberculosis
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3.1 Introduction
In sheep, MAP infection can give rise to three different forms of disease
with only about 30% of animals in an infected flock becoming clinically
affected. The majority of animals are asymptomatic! they are infected but
show no pathology and do not develop clinical disease. The remaining
clinically affected sheep show two distinct forms of the disease.
Approximately 30% of cases are affected by the paucibacillary form of
paratuberculosis! they have very few bacteria and show a T cell
infiltration into the gut. About 70% of cases have the multibacillary form,
which is characterized by a high level of bacterial infection and a
macrophage and B cell infiltration into the gut lamina propria. Both the
pauci- and multibacillary forms are equally fatal but there is no evidence
that the asymptomatic animals ever succumb to disease (52).
Paratuberculosis pathogenesis in cattle may differ from that in sheep as
it is presumed that there is disease progression from the asymptomatic to
paucibacillary and then to the fatal multibacillary form (230). In cattle, it
is estimated that 4-11% of animals in an affected herd are infected, with
2-4% of animals in such herds going on to develop clinical disease
(43,275). The paucibacillary cases tend to have a strong cell-mediated
immunity (CMI), high levels of IFNy and IL-2 and low levels of antibody
(6,35,36); the multibacillary cases have high antibody and pro¬
inflammatory cytokine levels and weak CMI (6,35). Little is known about
the asymptomatic form in cattle although they are positive for bacterial
growth, IS900 and specific antibody (41).
There have, as yet, been no studies giving a definitive description of the
three forms of paratuberculosis in sheep. Several studies have described
the difference between the paucibacillary and multibacillary forms
(41,183,231), mainly in terms of gross pathology, but all of these studies
ignored the presence of asymptomatic sheep. This short study aimed to
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generate a definition of the three pathologies in both histopathological
and molecular terms.
3.2 Definition of pathological forms
All animals from the Johne's disease infected flocks were identified as
IS900 positive in the ileum by real-time RT-PCR analysis and therefore
infected with MAP (Figure 3.1). The asymptomatic group were also IS900
positive in the mesenteric lymph node (MLN) confirming that the ileum
IS900 positive results were not due to surface bacteria. Three groups of
IS900+ animals could be discriminated on the basis of gross pathology,
ZN staining and histopathology. The asymptomatic group had no clinical
signs of paratuberculosis, on post-mortem showed no evidence of the
presence of acid-fast bacteria (ZN-) and exhibited normal histology of the
terminal ileum (Figures 3.2, 3.3, 3.4). All other sheep showed clinical
signs of paratuberculosis and could be differentiated into two groups on
the basis of ZN staining. The paucibacillary sheep had no detectable ZN+
bacteria (Figure 3.5) and showed a mixed inflammatory infiltrate into the
lamina propria (Figure 3.6) comprising lymphocytes, eosinophils (Figure
3.7, small arrows) and multinucleate giant cells (Figure 3.7, large arrow)
but few macrophages. The multibacillary sheep had high numbers of ZN+
acid-fast bacteria (Figure 3.8) associated with infiltrating sheets of
epithelioid macrophages, which distend the lamina propria and flattened
the surface mucosa (Figure 3.9 & 3.10). A fourth group of unrelated,
control sheep was IS900 negative and therefore defined as uninfected
with MAP. All of the multibacillary animals, 2/6 of the paucibacillary
animals and none of the asymptomatic animals tested positive for MAP
specific antibodies by antibody ELISA (Table 3.1). These results are
summarised in Table 3.2. CMI responses were not analysed as they have
been previously described in sheep (35) and the intention of the study was
to quantify the expression of IFNy as part of the gene expression studies.
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Figure 3.1: Results of IS900 real-time RT-PCR Graphs show fluorescence versus cycle
number. Large arrows indicate positive control, small arrows indicate negative control. Each
line represents one sample - a line curving upward and crossing the threshold value is
considered positive, (a) depicts results for multibacillary samples, (b) depicts results for
paucibacillary samples, (c) depicts results for asymptomatic samples and (d) depicts results
for control sheep samples.
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Figure 3.2: Histopathology of the terminal ileum from asymptomatic sheep
Ziehl-Neelsen stain for acid-fast bacteria (x 250) showing the absence of mycobacteria
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Figure 3.3: Histopathology of the terminal ileum from asymptomatic sheep
H&E stained low power (250x) showing normal histology.
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Figure 3.4: Histopathology of the terminal ileum from asymptomatic sheep
H&E stained high power (x400) showing normal histology.
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Figure 3.5: Histopathology of the terminal ileum from paucibacillary sheep
Ziehl-Neelsen stain (x250) showing the absence of mycobacteria.
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Figure 3.6: Histopathology of the terminal ileum from paucibacillary sheep
H&E stained low power (x250) showing mixed inflammatory infiltrate into lamina propria
comprising lymphocytes, eosinophils, macrophages and multinucleate giant cells.
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Figure 3.7: Histopathology of the terminal ileum from paucibacillary sheep
H&E stained high power (x400) showing multinucleate giant cells (large arrow). There is an
associated proprial inflammatory reaction dominated by lymphocytes and eosinophils
(small arrows).
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Figure 3.8: Histopathology of the terminal ileum from multibacillary sheep
Ziehl-Neelsen stain (x 250) showing the presence of many intracellular mycobacteria
associated with the infiltrating macrophages.
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Figure 3.9: Histopathology of the terminal ileum from multibacillary sheep
H&E stained low power (x250) showing infiltration of the lamina propria by sheets of
epithelioid macrophages distending the propria and flattening the surface mucosa.
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Figure 3.10: Histopathology of the terminal ileum from multibacillary sheep
H&E stained high power (x400) demonstrating the uniform population of macrophages with
abundant cytoplasm infiltrating around an intestinal crypt.
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Score of <60 is negative, >70 is positive
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Table 3.2: Definition of pathological forms
IS900 IS900
M0 Lymphocyte real-time real-time
infiltrate infiltrate in Antibody PCR on PCR on Pathological
Sample in Ileum ileum ELISA ileum MLN form
3 - + ND* + ND Paucibacillary
4 - + + + ND Paucibacillary
5 - + ND + ND Paucibacillary
6 - + - + ND Paucibacillary
7 - + - + ND Paucibacillary
8 - + - + ND Paucibacillary
9 - + ND + ND Paucibacillary
10 - + + + ND Paucibacillary
32 - + - + ND Paucibacillary
33 - + ND + ND Paucibacillary
11 + - + + ND Multibacillary
12 + - + + ND Multibacillary
13 + - + + ND Multibacillary
14 + - + + ND Multibacillary
16 + - + + ND Multibacillary
18 + - + + ND Multibacillary
27 + - ND + ND Multibacillary
28 + - ND + ND Multibacillary
29 + - ND + ND Multibacillary
30 + - + + ND Multibacillary
19 - - ND + + Asymptomatic
20 - - - + + Asymptomatic
21 - - - + + Asymptomatic
22 - - - + + Asymptomatic
23 - - - + + Asymptomatic
24 - - - + + Asymptomatic
25 - - - + + Asymptomatic
26 - - - + + Asymptomatic
31 - - ND + + Asymptomatic
34 - - + + Asymptomatic
35 ND ND ND - ND Control
36 ND ND ND - ND Control
37 ND ND ND - ND Control
38 ND ND ND • ND Control
39 ND ND ND - ND Control
40 ND ND ND - ND Control
41 ND ND ND - ND Control
42 ND ND ND - ND Control
43 ND ND ND - ND Control
*ND = not done
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3.3 Discussion
The three major mycobacterial diseases of mammals - tuberculosis,
leprosy and paratuberculosis affect different organ systems but share at
least two important characteristics. Firstly, not all infected individuals
become clinically affected and second, there are at least two pathological
forms of each disease (89,173). In human leprosy, the tuberculoid form of
the disease has lesions formed of infiltrating T cells and containing few
bacteria; and the lepromatous form has lesions of infiltrating
macrophages containing large numbers of bacteria (164). The pathological
picture of ruminant paratuberculosis seems to mimic human leprosy (55)
mainly in sheep where the pathology can be unambiguously
differentiated into tuberculoid (paucibacillary), lepromatous
(multibacillary) and asymptomatic (infected but no pathology) (53). There
are also differences between ovine and bovine paratuberculosis, as in
cattle the pathological form is thought to be related to the disease
development (55,230), with early stage tuberculoid lesions developing into
end-stage lepromatous disease. In addition, intermediate stages between
these two extremes have also been reported (90,136).
This study has shown that the three pathological forms can be defined
unambiguously by both histopathological and molecular means. Unlike
cattle, where asymptomatic animals are regarded as 'preclinical' and
show histological lesions (242), asymptomatic sheep show normal ileal
histology and do not succumb to disease (52). The asymptomatic sheep in
this study were shown to be infected by detection of IS900 by real-time
RT-PCR of both ileum and mesenteric lymph node tissues, proving that
these animals are infected with MAP. This result also allows
asymptomatic animals to be easily differentiated from uninfected
controls, which tested negative for IS900 in the ileum. MLN tissues from
control animals were not available and thus were not tested for IS900.
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Chapter 4: Differential cytokine gene expression
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4.1 Introduction
This study examined the expression of mRNA for thirteen candidate
genes involved in the polarisation of the immune response. Of these, one
(ILr3) was chosen from a preliminary microarray study carried out by
other members of the research group (191). The remaining twelve genes —
IL-la, IL-1B, IL-6, IL-8, IL-10, IL-12p40, IL-18, GM-CSF, IFNy, TGFB,
TNFa and TRAF-1 - were chosen from published sources. Several studies
in cattle have shown up-regulation of IL-8, IL-10, IL-12, GM-CSF, IFN-y,
TGFB, TRAF-1, IL-la IL-lB, IL-6 and TNFa and down-regulation of IL-18
in response to MAP infection (3,59,63,128,138,139,242,265,266). Although
little research has been done into gene expression in sheep in response to
MAP infection, studies using cytokine release assays and semi¬
quantitative RT-PCR have shown that multibacillary sheep have
increased expression of TNFa, IL-lB and IL-6 and paucibacillary sheep
have increased expression of TNFa, IFN-y and IL-2 during clinical
infection (6,36).
The T cells response in ovine paratuberculosis is central to control of
infection. y8 T cells are increased early at the site of infection (21,23,144),
and CD4+ and CD8+ cells are increased later in infection (144,186). The T
cell response later in infection is polarised, and leads to the observed
differences in pathology. In paucibacillary lesions, IL-2 and IFNy are
increased , leading to activation of macrophages and Thl cells (36,144).
Conversely, IFNy and TNFa are decreased in multibacillary lesions,
leading to lower macrophage activation and an increase in Th2 responses
(36,144). T regulatory cells (Tregs) have a CD4+CD25+FoxP3+
phenotype, and are capable of inducing anergy to self and foreign
antigens and preventing migration of immune cells to the site of infection
by the production of Th2 cytokines including IL-10 (273).
73
CHAPTER 4 DIFFERENTIAL CYTOKINE GENE EXPRESSION
The aim of this study was therefore to quantify cytokine gene expression
in the three pathologies of ovine paratuberculosis to gain insight into the
type 1 / type 2 immune responses present.
4.2 RNA extraction from ileum
RNA was successfully extracted from thirty-nine samples in total — ten
paucibacillary, ten multibacillary, ten asymptomatic and nine controls.
The concentration of RNA and RNA integrity number (RIN) for each
sample are given in Table 4.1. Samples without RIN numbers were
analysed on an earlier version of the Agilent software, which did not
assign a RIN number to the samples.
4.3 Sequences of cloned PCR products
Clones of PCR products were sequenced in one direction using T7 primer.
The sequences of the clones and the percentage alignment with the
expected sequence are given in Appendix 2.
4.4 Gene expression analysis in ileal tissues
4.4.1 Generation of standard curves
Standard curves were generated from linearised plasmid DNA for all
candidate genes. Standard curves with an efficiency between 0.9 and 1.1,
an M value (a measure of the gradient of the slope) of around -3.3 and R2
values (a measure of how well the standards fit onto a curve) of as close to
1 as possible were acceptable. Figure 4.1b shows an acceptable standard
curve, with values close to ideal. Sample cDNA is arrowed. Figure 4.Id
shows an unacceptable standard curve. Standard curves with values like
these were rejected, plasmid DNA samples replaced and the reactions
repeated.
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3 Pauci 888 8.9
4 Pauci 985.6 8.5
5 Pauci 998.4 9.1
6 Pauci 1032.8 9
7 Pauci 324 8
8 Pauci 458.4 9.7
9 Pauci 671.2 9.5
10 Pauci 730.4 6.8
32 Pauci 224 ND*
33 Pauci 496 ND
11 Multi 698.4 8.9
12 Multi 460 8.6
13 Multi 1072 7.3
14 Multi 1249 9.1
16 Multi 1035.2 8.6
17 Multi 1500.8 8.2
27 Multi 904 9.6
28 Multi 1216 8.6
29 Multi 456 ND
30 Multi 408 ND
19 Asymp 515.2 8
20 Asymp 265 9
21 Asymp 260.8 6
22 Asymp 730.4 8.2
23 Asymp 918.4 9
24 Asymp 928 8.4
25 Asymp 528 8.5
26 Asymp 872 8.9
31 Asymp 392 ND
34 Asymp 496 ND
35 Control 826 ND
36 Control 804 ND
37 Control 763.2 ND
38 Control 771.2 ND
39 Control 632 ND
40 Control 660.8 ND
41 Control 621.6 ND
42 Control 491.2 ND
43 Control 520.8 ND
*ND = not done
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Figure 4.1: Generation of linearised plasmid DNA standard curves for real-time PCR
(a) Fluorescence versus cycle graph for a standard curve - spacing is even between plasmid
dilutions. Laiye ai iuw indicates cDNA control, small arrow indicates no template control
(NTC). (b) Standard curve taken from (a). All values are close to ideal, and points sit well on
the line, (c) Fluorescence versus time graph for an unacceptable standard curve - uneven
spacing between plasmid dilutions. Large arrow indicates cDNA control, small arrow
indicates NTC. (d) Standard curves taken from (c). The efficiency is unacceptably low.
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4.4.2 Real-time RT-PCR analysis of mRNA expression
The expression levels of the thirteen candidate genes are shown in Table
4.2, which lists normalised mean copy numbers of each gene in the three
disease types and controls. From these data it can be seen that the genes
were expressed at very different levels, varying from less than 100 copies
(e.g. ILrla, IL-3) to greater than lxlO6 copies (e.g. IL-8). There was also a
great deal of variation in the expression levels between the four types of
samples, as reflected in the large standard deviations. The variation is
due to the experimental animals being outbred, from different farms and
of different ages.
The differences in gene expression can be seen more clearly in Figures 4.2
and 4.3. These graphs show statistically significant (p<0.05) fold-changes
in the six comparisons. Fold-changes less than 2.2 but statistically
significant are included in the comparisons (Section 2.8.5). Two genes -
IL-la and GM-CSF - did not exceed 2.2 fold-change in any statistically
significant comparison.
Figure 4.2 shows the comparison of the transcript levels between the
infected groups and the uninfected control group. IL-la, IL-8, IL-12p40,
GM-CSF, IFNy, TGFB, TNFa and TRAF-1 were significantly up-
regulated, and IL-18 was significantly down-regulated in paucibacillary
samples. IL-8, IFNy, TGFB, TNFa and TRAF-1 were significantly up-
regulated in multibacillary samples. Interestingly, TNFa was
significantly up-regulated and IL-18 significantly down-regulated in
asymptomatic samples. IL-3 was detected at low levels in all infected
animals but never in uninfected control samples! therefore it was not
possible to produce fold-change figures for these comparisons.
Nevertheless, IL-3 was statistically significantly up-regulated (p<0.05) in
both multibacillary and asymptomatic samples (but not paucibacillary
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sheep) compared to controls using the non-parametric Mann-Whitney
test.
Figure 4.3 shows the comparisons between the three infected groups of
sheep. When the clinically diseased groups were compared to the
asymptomatic group, ILrlO, IL-18, TGFB, TNFa and TRAF-1 were up-
regulated in multibacillary animals and IL-lB, IL-6, IL-18, GM-CSF,
IFNy and TRAF-1 were up-regulated in paucibacillary animals. IL-10
was down-regulated in paucibacillary samples compared to multibacillary
samples.
78
CHAPTER 4 DIFFERENTIAL CYTOKINE GENE EXPRESSION
Table 4.2: Copy numbers of all genes of interest in all groups normalised to
reference gene expression.
Multibacillary Paucibacillary Asymptomatic Control
IL-lcx 69 38 51 20
± 56 ± 14 ± 42 ± 8
IL-1|3 30,839 16,470 4176 8613
±41,353 ± 8559 ± 2557 ±6090
IL-3 29 1 87 0
± 74 ±3 ± 131 ± 0
IL-6 71,778 11,023 4996 5473
± 124,310 ±2980 ± 1698 ± 7583
IL-8 1,448,098 609,805 480,573 150,388
± 1,453,346 ± 511,880 ± 601,312 ± 59,472
IL-10 305,964 174,186 126,941 240,619
± 127,868 ± 82,536 ± 94,659 ± 185,599
IL-12p40 7178 7589 4506 1615
± 7381 ± 6467 ± 5179 ± 2436
IL-18 102,838 84,037 42,352 126,047
± 45,161 ± 34,888 ± 10,066 ± 41,771
GM-CSF 2512 2973 1786 1986
± 1067 ± 963 ± 684 ± 552
IFNy 3354 5209 2529 1537
± 1063 ± 2554 ± 1620 ±427
TGFp 50,349 28,007 21,871 14,519
± 30,161 ± 13,809 ± 11,222 ±6032
TNFa 21,113 11,681 7492 2770
± 13,334 ± 7914 ± 4925 ± 2120
TRAF-1 11,504 20,087 5018 3708
± 6076 ± 10,563 ±5134 ± 1662
Bold denotes statistical significance (p^O.05) compared to uninfected control
animals. Figures are shown ± standard deviation.
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Figure 4.2: Statistically significant fold-changes in genes in infected animals
compared to uninfected control groups Results are given as fold-changes of mean copy-
numbers relative to the mean copy-numbers of the uninfected control group and p< 0.05. IL-
3 was not included, as the copy-number in the control samples was 0, thus fold change
values could not be calculated. (*) indicates fold-changes greater than 2.2.
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Multibacillary versus Asymptomatic
IL-10 IL-18 TGF-p TNFa TRAF-1
Paucibacillary versus Asymptomatic
4.5
















Figure 4.3: Statistically significant fold-changes in genes in the three infected groups
Results are given as fold-changes of mean copy-numbers of infected groups relative to the
mean copy-numbers of each other group and p< 0.05. (*) indicates fold-changes greater
than 2.2.
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4.5 Discussion
Despite the fact that there is a large variation in the levels of cytokine
transcript expression, this study showed unambiguously that there is a
relationship between the three pathological forms of sheep
paratuberculosis and the immune response as represented by the
cytokine transcript profiles within the target tissue. The large variation is
probably due to the fact that these sheep are unrelated, of different
breeds and are infected naturally rather than experimentally; in addition
they carry a variable gastrointestinal worm burden (see section 2.1.1)
that might influence ileal cytokine expression. We cannot measure levels
of functional protein for all the cytokines within the ileum but assume
that the relative quantities of cytokine protein and transcript are linked.
As has been shown with bovine paratuberculosis (63,138,242), the
paucibacillary and multibacillary forms of the sheep disease are also
associated with the polarization of the immune response. The comparison
of each form of the disease with tissue from asymptomatic animals shows
that IFNy is significantly increased in the paucibacillary lesions and IL-
10 is raised in the multibacillary form, although only IL-10 is
significantly different when the two clinical forms are directly compared.
This confirms that in sheep paratuberculosis polarised Thl and Th2 cells
are associated with paucibacillary and multibacillary pathology
respectively. However, the polarisation is incomplete. The major
biological function of ILrl8 seems to be linked to inducing type 1
responses and stimulating IFNy production (70). However, the pattern of
IL-18 expression is up-regulated in both disease forms compared to
asymptomatic samples. Similarly, both the paucibacillary and
multibacillary groups displayed up-regulation of TGF6, a regulatory
cytokine with known anti-inflammatory and immunosuppressive
functions in inflammatory bowel diseases (22). This up-regulation may
explain why, unlike in other gastrointestinal inflammatory lesions (77),
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the expression of large quantities of pro-inflammatory cytokines in
paratuberculosis is not reflected in the large scale infiltration of
neutrophils.
In addition, up-regulation of IL-8, TRAF-1, and TNFa was observed when
both types of clinically diseased samples were compared to uninfected
controls, reflecting the high levels of inflammation present in these
samples. ILrla and ILrl2 were also up-regulated in these samples, but
the difference was not significant in multibacillary animals (p=0.081 and
0.06, respectively), again reflecting high levels of inflammation. The IL-12
result contradicts previous studies in bovine ileum tissues and stimulated
PBMCs from infected cattle, that have shown down-regulation of IL-12 in
infected cattle compared to controls (63,242). This may be due to
differences in tissue source or in species specific host responses.
IL-lB and IL-6 were significantly up-regulated in paucibacillary samples
compared to asymptomatic samples, and hugely up-regulated in
multibacillary samples compared to asymptomatic samples, although this
was not statistically significant (p=0.133 and 0.167, respectively). These
genes have both previously been associated with multibacillary disease
(6) and again probably indicate high levels of inflammation. The
expression of IL-6 has long been known to be associated with parasitic
worm infections (245). As the sheep in this study were kept outside and
mixed with other sheep, many of them had parasitic infections, which
may have contributed to the high levels of variation in expression levels.
GM-CSF, a cytokine produced by Thl cells involved in production and
activation of granulocytes and macrophages, was up-regulated in
paucibacillary samples, leading to further polarisation of the response
toward a Thl profile.
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Of particular interest was the comparison between the infected,
asymptomatic and the uninfected, control sheep. Asymptomatic sheep
show completely normal ileal histology and do not succumb to disease
(52). This normality is largely confirmed by the fact that the majority of
cytokines are expressed at 'normal' levels; however TNFa and IL-18 are
exceptions - IL-18 was down-regulated and TNFa was up-regulated in
asymptomatic sheep compared to controls. Up-regulation of
proinflammatory cytokines such as TNFa would be expected to lead to an
inflammatory response. However, these sheep have little or no
inflammation in the gut, suggesting that this response is being well
controlled. The down-regulation of IL-18 also suggests that a regulatory,
anti-inflammatory response is dominating in these sheep.
IL-3 was detected at low levels in all infected samples but not in the
uninfected controls. In tuberculosis in human cells, IL-3 is associated
with the formation of granulomata containing multinucleated giant cells,
and IL"3 treatment of infected cell cultures dramatically reduces the
number of infectious bacteria present. IL-3 treatment also prevents cell-
cell spread of the bacteria (38), and can enhance the survival of dendritic
cells involved in Th2 cell differentiation (79,195,250). However, the
extremely low level of detection of this cytokine leaves doubts as to its
biological significance in the ileum of MAP infected sheep.
Although this study represents a robust and replicable quantification of
cytokines involved in paratuberculosis pathologies, the method does have
several drawbacks. Using pDNA for the standard curves, as is required
for absolute quantification, may not be an accurate measure of the gene
in a cDNA sample. The pDNA is not reverse transcribed, and thus cannot
reflect or control for variation introduced during this step. Secondly, it
cannot exactly reflect the behaviour of the cDNA samples during the
assay, as it is a purer sample and does not contain DNA of any other
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sequence which could interfere with the assay, unlike cDNA samples.
Also, the presence and amount of cDNA quantified for a gene may not
directly relate to the presence and quantity of that particular protein in a
cell.
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Chapter 5: Differential expression and SNP
analysis of non-cytokine genes
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5.1 Introduction
In addition to the cytokine genes described in Chapter 4, the expression of
a further selection of relevant immune genes was quantified. Several
genes - CD34, CXCR4, IGFBP-2 and IGFBP-6 - were again chosen from
previous microarray data (191) on the basis of differential expression in
multibacillary and paucibacillary animals. CXCR4 is known to be
associated with type 2 immune responses, and CD34 is a marker for
haematopoietic stem cells. Little is known about the role of IGFBPs in
pathogenesis, although they are known to control the actions of IGFs,
leading to a reduction in proliferation. TIRAP and TRAM were chosen
from published sources in order to further understand the role of TLR
signalling in paratuberculosis (166). Only IGFBP-6 had been previously
quantified in sheep paratuberculosis (62).
Of these additional genes, two were selected for SNP analysis based on
their expression profiles — IGFBP-6 and CXCR4. Both of these genes were
differentially expressed in paucibacillary animals compared to
multibacillary animals, with CXCR4 being down-regulated and IGFBP-6
being up-regulated. SNPs are defined as single base pair positions in
genomic DNA at which different sequence alleles exist in normal
individuals in some populations, wherein the least frequent allele has an
abundance of 1% or greater (33). SNPs account for much of the genetic
variation between individuals in a population and if found within the
coding region of a gene can lead to differences in the amino acid sequence
coded for and thus can change the protein structure of the product of the
gene. If found within the upstream promoter regions of a gene they can
affect regulation of gene expression. They can also be used as markers for
particular genetic traits (33). The aim of this study was to analyse the
sequence of the coding regions of the IGFBP-6 and CXCR4 genes to look
for disease specific SNPs, which could go some way towards explaining
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the differences in gene expression between sheep with different forms of
paratuberculosis.
The role of these two genes in clinical paratuberculosis is very unclear.
CXCR4 is a receptor for CXCL12 and is expressed on the cell surface of
all B cells, monocytes, natural killer cells and most T cells
(31,121,160,190,194) and IGFBP-6 has been well known for some time as
a regulator of IGFTI (13), a growth factor involved in cell proliferation.
5.2 Real-time RT-PCR analysis of gene expression
RNA was extracted and PCR products cloned and sequenced and
standard curves generated as described in Chapter 4. The expression
levels of the six candidate genes are shown in Table 5.1, which lists mean
copy numbers of each gene in the three disease types and controls
normalised to SDHA expression. From these data it can be seen that the
genes were expressed at very different levels, varying from less than 300
copies (e.g. IGFBP2, IGFBP6) to greater than 30000 copies (e.g. CXCR4).
There was also a great deal of variation in the expression levels between
the four types of samples.
The differences in gene expression can be seen more clearly in Figures 5.1
and 5.2. The high degree of variation in gene expression was due to the
nature of the samples used - the sheep were out bred and from different
farms, thus the external influences on these sheep varied greatly. These
graphs show statistically significant (p<0.05) fold-changes in the six
comparisons. Fold-changes less than 2.2 but statistically significant are
included in the comparisons (Section 2.8.5). IGFBP-2 expression was not
significantly different in any comparison, and in two genes — CD34 and
TRAM — the fold-change did not exceed 2.2 for any comparison.
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Table 5.1: Copy numbers of all genes of interest in all groups normalised to
reference gene expression.
Multibacillary Paucibacillary Asymptomatic Control
CD34 1901 2622 1937 3568
± 1017 ± 1525 ± 1086 ± 1097
CXCR4 26,980 12,702 4401 31,495
± 15,227 ±6646 ±2153 ±21,406
IGFBP-2 778 485 354 271
±578 ± 420 ± 237 ±61
IGFBP-6 259 657 354 269
± 106 ± 303 ± 127 ± 117
TIRAP 2863 3905 8281 6263
±1244 ±2115 ± 2921 ± 1716
TRAM 329 466 317 584
± 115 ± 159 ± 108 ± 180
Bold denotes statistical significance compared to uninfected control animals.
Figures are shown ± standard deviation
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Figure 5.1: Statistically significant fold-changes in genes in infected animals
compared to uninfected control groups Results are given as fold-changes of mean copy-
numbers relative to the mean copy-numbers of the uninfected control group and p< 0.05. (*)
indicates fold-changes greater than 2.2.
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Figure 5.2: Statistically significant fold-changes in genes in the three infected groups
Results are given as fold-changes of mean copy-numbers in infected groups relative to the
mean copy-numbers in each of the other infected groups and p^ 0.05. (*) indicates fold-
changes greater than 2.2.
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Figure 5.1 shows the comparison of the transcript levels between the
infected groups and the uninfected control group. CD34, TIRAP and
TRAM were significantly down-regulated in multibacillary samples
CXCR4 and TIRAP were significantly down-regulated, and IGFBP-6 up-
regulated in paucibacillary samples. CXCR4, CD34 and TRAM were
significantly down-regulated in asymptomatic samples.
Figure 5.2 shows the comparisons between the three infected groups of
sheep. In both multibacillary and paucibacillary samples, CXCR4 was up-
regulated and TIRAP down-regulated compared to asymptomatic
samples. IGFBP-6 was also up-regulated in paucibacillary samples
compared to asymptomatic samples. CXCR4 was down-regulated and
IGFBP'6 up-regulated in paucibacillary samples compared to
multibacillary samples.
CXCR4 and IGFBP-6 were selected for SNP analysis because they were
differentially expressed in paucibacillary and multibacillary samples.
5.3 Extraction of genomic DNAfrom paratuberculosis tissues
In order to perform the SNP analysis, genomic DNA was successfully
extracted from thirty samples in total — ten paucibacillary, ten
multibacillary and ten asymptomatic. The concentration of DNA
extracted from each sample is given in Table 5.2.
5.4 CXCR4 sequence and PCR fragments
Bovine genomic and full-length CXCR4 mRNA (Accession number:
NM_174301.3) sequences were obtained from Genbank and aligned to
identify CXCR4 exons within the bovine genomic sequence. The CXCR4
gene is found on chromosome two and consists of two exons and one
intron as depicted in Figure 5.3. Primers were designed to amplify all of
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the coding regions and the intron/exon boundaries where possible. The
positions of the CXCR4 primers are depicted in Figure 5.3.
5.5 IGFBP-6 sequence and PCR fragments
Bovine genomic and full-length IGFBP-6 mRNA (Accession number^
NM_001040495.1) sequences were obtained from Genbank and aligned to
identify IGFBP-6 exons within the bovine genomic sequence. The IGFBP-
6 gene is found on chromosome five and consists of four exons and three
introns as depicted in Figure 5.4. Primers were designed to amplify all of
the coding regions and the intron/exon boundaries where possible. The
positions of the IGFBP-6 primers are depicted in Figure 5.4.
5.6 Production of PCR products
PCR products Cl, C2, C3 and C4 and IGl, IG2, IG3 and IG4 were
generated by PCR from all samples. PCR product C5 was generated from
samples 3, 4, 6"22 and 24"32 by PCR. It was not possible to generate this
product from samples 5 and 23 — possibly due to mutations in the
genomic sequence of these samples preventing primer binding, or the
presence of an inhibitor in the DNA sample. These samples were purified
and quantified.
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Table 5.2: DNA sample concentrations
DNA
Concentration Extraction
Sample Type (pg/ml) kit
1* Asymp 217.2 DNEasy
2* Asymp 32.6 DNEasy
3 Pauci 33.5 DNEasy
4 Pauci 191.0 DNEasy
5 Pauci 67.0 DNEasy
6 Pauci 81.1 DNEasy
7 Pauci 50.6 DNEasy
8 Pauci 231.2 FastDNA
9 Pauci 211.3 FastDNA
10 Pauci 238.7 FastDNA
32 Pauci 53.1 DNEasy
34 Pauci 95.4 DNEasy
11 Multi 120.8 FastDNA
12 Multi 162.2 FastDNA
13 Multi 203.6 FastDNA
14 Multi 203.5 FastDNA
16 Multi 170.0 FastDNA
17 Multi 274.6 FastDNA
27 Multi 235.5 FastDNA
28 Multi 181.8 FastDNA
29 Multi 238.0 FastDNA
30 Multi 196.9 FastDNA
19 Asymp 35.6 DNEasy
20 Asymp 98.0 DNEasy
21 Asymp 47.1 DNEasy
22 Asymp 54.6 DNEasy
23 Asymp 62.3 DNEasy
24 Asymp 38.0 DNEasy
25 Asymp 59.0 DNEasy
26 Asymp 96.6 DNEasy
31 Asymp 84.9 DNEasy
33 Asymp 74.6 DNEasy
*samples used for primer optimisation, but not in final analysis
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Figure 5.3: Schematic diagram of the structure of the bovine CXCR4 gene. Boxes













Figure 5.4: Schematic diagram of the structure of the bovine IGFBP-6 gene. Boxes
represent exons and square brackets indicate the length of the fragments amplified by the
sequencing primers.
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5.7 Cloning and sequencing of PCR products
All PCR products were successfully cloned and the plasmid extracted and
sequenced. At least three minipreps were prepared for each sample with
each of the nine PCR products, and at least one correct sequence was
obtained for each sample and PCR product. A correct sequence was
classed as a plasmid containing the insert of interest and of sufficient
quality to allow unambiguous reading of the sequence. The number of
correct sequences obtained for each PCR product and sample are shown
in table 5.3.
5.8 SNP analysis of CXCR4
Analysis of the consensus CXCR4 sequences revealed the presence of
three SNPs — two in the second PCR fragment and one in the fifth. These
were a C to T change at position 2169 (Figure 5.5a), a G to A change at
position 2364 (Figure 5.5b) and a G to A change at position 3523 (Figure
5.5c). Sequences containing SNPs are shown aligned with the sequence of
sample 6, which contained no SNPs.
When these SNPs were analysed by disease type, all the SNPs were
found in all three disease types (Table 5.4), and there were no significant
associations. The first SNP was equally common in asymptomatic and
paucibacillary samples. The second SNP was most common in
asymptomatic samples, and the third SNP was most common in
multibacillary samples. The SNPs were also analysed by breed, to ensure
that the SNPs were not breed specific. All of the SNPs were found in
sheep of a mix of breeds.
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Table 5.3: Number of correct sequences for each sample
PCR Number of correct
Product sequences Samples
CI 3 3-32
C2 3 4-7, 9-11, 13-24, 26-34
2 3, 8, 12, 25
C3 3 4, 7-9, 11-21, 23-26, 28, 30-34
2 3, 5, 6, 10, 22, 29
1 27
C4 3 3, 4, 6-11, 13-16, 19-23, 26-31, 33, 34
2 5, 9, 12, 17, 24, 25, 32
C5 3 3-7, 9-22, 25, 26, 28*34
2 8, 23, 24, 27
IGl 3 4-11, 13, 16-19, 21-27, 29*34
2 14, 20, 28
1 3, 12
IG2 3 4*9, 12-25, 27, 28, 31*34
2 S, 10, 11, 26, 30
1 29
IG3 3 3-8, 10-27, 29-34
2 9, 28
IG4 3 3, 5, 6, 8-11, 13-31, 33, 34
2 4, 7, 12, 32
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(A)
2122 TCTATTCCCTTGCCTGTTTTTCAGATATTCACTTCCGATAATTACACCGAGGATGACTTG 2181
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I
2122 TCTATTCCCTTGCCTGTTTTTCAGATATTCACTTCCGATAATTACACTGAGGATGACTTG 2181
(B)
23 62 AGGCTGCACCTGTCTGTGGCGGACCTCCTCTTTGTCCTCACACTTCCCTTCTGGGCGGTT 24 21




I I I I I I I I II II I I I II I I I I I I I I II I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
3479 AAATGGTTCTCAGCTGTTTGTAAATAAATGATCTCTCCATTCCAMTGGAACATTTTCTTT 3538
Figure 5.5: Position of SNPs in the CXCR4 gene (A) alignment of reference sequence 21
against sequence 31 containing SNP at position 2169. (B) alignment of reference sequence
21 against sequence 26 containing SNP at position 2364. (C) alignment of reference
sequence 21 against sequence 30 containing SNP at position 3523.
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Table 5.4: Samples and disease groups containing the three CXCR4 SNPs
Number of samples of each disease
type
SNP Samples M P A
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5.9 SNP analysis of IGFBP-6
Analysis of the consensus IGFBP-6 sequences revealed the presence of
three SNPs - one in each of the first, third and fourth PCR fragments.
These were a C to A change at position 63 (Figure 5.6a), a G to A change
at position 2776 (Figure 5.6b) and a G to A change at position 3822
(Figure 5.6c). Sequences containing SNPs are shown aligned with the
sequence of sample 4, which contained no SNPs.
When these SNPs were analysed by disease type (Table 5.5), both of the
first two SNPs (C>A at 63; G>A at 2776) were found in all three disease
types, and were both equally distributed among the three types. The third
SNP (G>A at 3822) was only found in clinically diseased animals, and
most commonly in multibacillary samples. The SNPs were also analysed
by breed, to ensure that the SNPs were not breed specific. All of the SNPs
were found in sheep of a mix of breeds.
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(A)
61 CA|AGGCTGCTGCCGCCACTGCTGCTAACTTTGCTGCTCGCTGCCCGCCCAGGAGGCGCC 120




I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
2725 ACGTGCCTAATTGTGACCATAGGGGCTTCTATCGGAAGCGGCAGGTGAGGCCATTCCTCC 278 4
(C)
3800 CTCACCCCTGGGACCTCACATGTGGAAAGATTGTTGGTGTCGGCCTGGGGTATTAATAAA 3859
I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I [
3800 CTCACCCCTGGGACCTCACATATGGAAAGATTGTTGGTGTCGGCCTGGGGTATTAATAAA 3859
Figure 5.6: Position of SNPs in the IGFBP-6 gene (A) alignment of reference sequence 23
against sequence 29 containing SNP at position 63 (B) alignment of reference sequence 23
against sequence 7 containing SNP at position 2776 (C) alignment of reference sequence 23
against sequence 6 containing SNP at position 3822.
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Table 5.5: Samples and disease groups containing the three IGFBP-6 SNPs
Number of samples of each disease
type
SNP Samples M P A
C>A 63 6, 24, 29 1 1 1





G>A 3822 6, 29, 30
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5.10 Discussion
One of the most unexpected findings of this study was that several genes
were significantly differently expressed in asymptomatic samples
compared to uninfected controls - CD34, CXCR4 and TRAM were down-
regulated. The decrease in CD34 expression probably reflects the lower
number of haematopoietic cells present, and the down-regulation of
CXCR4 may reflect good control of the immune response. As these sheep
are known to be infected with MAP but show no clinical or
histopathological signs of disease, these responses may represent the
'best-case scenario' after infection with MAP. This is further supported by
the expression profiles in the other infected groups— CXCR4 is down-
regulated in paucibacillary sheep, which control bacterial multiplication,
and is up-regulated in multibacillary animals, which do not control
bacterial proliferation. All of the groups have down-regulation of TIRAP,
a TLR regulatory molecule, suggesting that MAP infection can lead to
down-regulation of the TLR response. TRAM is involved production of
secretory proteins. The down-regulation of TRAM in asymptomatic
samples may reflect a reduction in cell activation and thus protein
production.
One of the main aims of this study was to find genes differentially
expressed in paucibacillary and multibacillary in order to try to
understand what governs which type of end-stage disease develops. Two
genes were significantly differentially expression - CXCR4 and IGFBP-6.
Both of these genes were chosen from previous microarray data (191).
The CXCR4 gene has been recently cloned (145) and found to encode a G-
protein-coupled receptor with seven transmembrane domains (121). It is a
member of the a chemokine family and the main receptor for CXCL12,
also known as stromal cell derived factor-1 (SDF-l) (112). The CXCR4
signalling pathway is illustrated in Figure 5.7. When CXCL12 binds to
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CXCR4, G-protein signalling pathways are activated. This can lead to
regulation of gene expression through the production of NFKB, STAT3
and ELK1. BCARl is produced, which leads to enhanced cell migration.
This is further enhanced by the activation of ITGA4, ITGAL and ITGAM,
cell surface molecules involved in cell adhesion.
CXCL12 and CXCR4 play a central role in the chemotaxis of
haematopoietic stem cells (HSC). CXCL12 is expressed on stromal cells in
bone marrow and promotes trafficking of HSC to the bone marrow (39).
CXCR4+ bone marrow cells can develop into both B and T cells, and
CXCR4 deficiency can result in reduced expansion of thymocyte
populations during embryogenesis, suggesting that CXCR4 is involved in
B and T cell development (106,129). CXCR4 may also play a role in the
homing of B and T-cells to the lymph nodes and inflamed tissues (39,160).
CXCR4 is expressed on the cell surface of all B cells, monocytes, natural
killer cells and most T cells (31,121,160,190,194), and all subsets migrate
towards CXCL12 (40). In T cells, CXCR4 expression is higher in naive
and T regulatory cells than in Thl and Th2 cells (204). Most studies
report no differences in expression of CXCR4 between Thl and Th2 cells
(31,64,194), although this is contradicted by a challenge study in mice
using either Mycobacterium bovis purified protein derivative or
Schistosoma mansoni egg-antigen coated beads. This showed that a
CXCR4 antagonist had little effect on Thl type granulomata induced by
M. bovis, but the Th2 type lesions induced by S.mansoniwere significantly
reduced, suggesting that CXCL12 is more highly expressed in the Th2
model (112). It has been reported that CXCR4 can associate with T cell
receptors (135) and may play a role in the survival of mature T cells and
the generation of memory T cells (129). Recent studies have also
suggested that CXCR4 could inhibit expression of MHC class II (215).
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Figure 5.7: CXCR4 signalling pathways
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The expression of CXCR4 has been shown to be up-regulated in patients
with Crohn's disease (7) and in patients and cells infected with
Mycobacterium tuberculosis (107,123,140).
CXCR4 expression is regulated by several inflammatory cytokines.
CXCR4 expression is up-regulated by IFNy in whole blood (123,176) but
down-regulated by IFNy in human monocytes (179). CXCR4 expression is
also up-regulated by TNFa, ILr2, IL-4, IL-7, ILrlO, IL-12 and IL-15
(7,121,129,176).
CXCR4 was found to be down-regulated in both paucibacillary and
asymptomatic samples compared to uninfected controls. This is
inconsistent with previous studies on macrophages showing up-regulation
of CXCR4 in mycobacterial infection (107,158). Down-regulation of
CXCR4 in paucibacillary and asymptomatic samples may be a
mechanism to prevent CXCR4 mediated down-regulation of MHC class II.
There are currently six known insulin-like growth factor binding proteins
(IGFBP-1-6), all of which bind insulin-like growth factors (IGF) I and II.
IGFBP-6 is unique among these as it binds with high affinity to IGFTI,
while binding with very low affinity to IGFT (13,100,125). This difference
in binding affinity is due to the unique structure of the C terminal of
IGFBP-6, which is responsible for binding IGFTI (100). IGFBP-6 is also
unique in its N terminal disulphide links, further differentiating it from
other IGFBPs (14).
Through its high affinity binding to IGFTI, IGFBP-6 inhibits many of the
functions of IGFTI, including proliferation and differentiation (92,241).
Transgenic mice engineered to over express IGFBP-6 have reduced body
weights and litter size, suggesting that IGFTI has central roles in growth
and reproduction (30). IGFBP-6 also promotes apoptosis in some cell
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types, including rhabdomyosarcoma cells and neurones (13,30), and may
have a role to play in the development of the central nervous system. It is
also important in the control of proliferation in several cancers, and can
be up-regulated in some renal cell carcinomas (13,47).
As yet, little is known about the role of IGFBP-6 in infectious disease,
although it has previously been shown to be up-regulated in cattle
PBMCs stimulated with MAP (62). It is known to be up-regulated in
humans in critical illness, and may play a role in transporting IGF-II
from the blood into tissues (20). Expression of IGFBP-6 has previously
been reported to be inhibited by the presence of TGF13 (150), although
these results in paucibacillary animals contradict this, with up-regulation
of both TGF8 and IGFBP-6. Previous studies have also shown that
IGFBP-6 expression is required for pro-B cell development (241).
This present study has shown significant up-regulation of IGFBP-6 in
paucibacillary samples compared to all others. In paucibacillary infection,
it is possible that IGFBP-6 expression could play a role in controlling
proliferation in the infected tissues by preventing the actions of IGF-II
and inducing apoptosis. Conversely, IGFBP-6 plays a role in transporting
IGF-II to the infected tissues, thus increasing proliferation and
differentiation of cells in the infected areas.
Due to their differential expression in multibacillary and paucibacillary
sheep, CXCR4 and IGFBP-6 were selected for SNP analysis of their
coding regions. This analysis aimed to discover whether similar SNPs
exist within the coding regions of the CXCR4 and IGFBP-6 genes in
sheep, and whether these SNPs were associated with the pathology.
This real-time PCR study found that CXCR4 was down-regulated in
paucibacillary and asymptomatic samples compared to controls.
Expression in multibacillary samples was similar to controls. It was
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expected, therefore, that any SNPs discovered would be associated with
the multibacillary form of the disease. Three SNPs were discovered in the
CXCR4 gene. Functional analysis of these SNPs revealed that the SNPs
at positions 2169 and 2364 are contained within the coding region of the
gene, but are silent and thus unlikely to affect gene function. The SNP at
position 3523 is in the 3' untranslated region of the gene, and thus cannot
affect the gene function, but could affect gene regulation or mRNA
translation.
As all of the CXCR4 SNPs are found in all of the types of disease, and
none in all of one particular type, it is unlikely that these SNPs are
responsible for the differential expression of CXCR4 seen in the three
disease types. The samples size in this experiment is too small for any
definite conclusions to be reached. However, it was considered unlikely
that any of these changes could explain the difference in gene expression
observed in the previous study.
This real-time PCR study found that IGFBP-6 was up-regulated only in
paucibacillary samples. It was therefore expected that any SNPs found
would associate with the paucibacillary form of the disease. Three SNPs
were discovered in the IGFBP-6 gene. Functional analysis of these SNPs
revealed that the SNP at position 63 is contained within the coding region
of the gene which leads to a change in the fourth amino acid in the
IGFBP-6 protein from a histidine to glutamine. Histidine is a polar,
weakly basic amino acid and glutamine is a polar neutral amino acid of a
similar size to histidine. The change may not be significant since the two
amino acids have similar characteristics. This SNP was also found in
samples of all disease types, so could not be linked to a particular
pathology.
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The SNP at position 2776 is contained within the intron between exons
three and four. Although it could interfere with splicing and other
modification of the mRNA, it was found in equal numbers in each of the
three groups, suggesting that it does not affect gene function.
The SNP at position 3822 is in the 3' untranslated region of the gene, and
thus cannot affect the protein structure, but could affect gene regulation
or mRNA translation. It is possible that this SNP could be clinically
relevant as it is not observed in asymptomatic animals but investigation
of more animals would be needed to consolidate this finding. The SNP
was also only found in 3 out of 20 clinically diseased samples — two
multibacillary and one paucibacillary. Therefore many more sequences
from clinically diseased sheep would have to be analysed before definite
conclusions could be drawn.
In the future, it would be beneficial to expand these SNP analyses to
include upstream non-coding regions. This is where promoter and
regulatory regions are likely to be found, and any SNPs in these areas
could have a profound effect on gene expression.
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Chapter 6: Microarray analysis of gene expression
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6.1 Introduction
Competitive hybridisation of cDNA microarrays is a powerful method for
comparing host gene expression in different pathologies. Microarray
analysis allows hundreds of genes to be assayed in parallel and
significant interactions between these genes to be elucidated. Lower
consumption of reagents and samples results in a high number of genes
being analysed from smaller samples. Competitive hybridisations are an
ideal way of comparing gene expression between two different samples as
they reduce between chip variations and differences in reaction conditions
(198).
The results of such a host response study can be applied in several ways.
They can be used to detect novel pathways involved in pathogenesis or to
compare pathways involved in contrasting pathologies. Comparisons
between resistant and susceptible hosts can allow identification of genes
and pathways involved in protection and recovery, thus providing new
targets for treatment and vaccination (108).
Although microarray analysis is powerful, it also has its limitations.
There can be a high 'false-discovery' rate, leading to high numbers of
genes seeming to be differentially expressed when they are not. This is
controlled for during the normalisation process, when an adjusted p -
value is produced. It is also essential to validate the array by using real¬
time PCR to analyse the expression of genes found to be differentially
expressed in the microarray analysis. Microarray analysis must be done
to Minimum Information About a Microarray Experiment (MIAME)
standards, which allow easy interpretation and repetition of the
experimental results (32).
This analysis utilised the ruminant immunoinflammatory gene universal
array (RIGUA). The array has 4000 spots consisting of replicates of 600
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genes, each represented as 75bp oligomers, picked to represent genes
involved in all aspects of the ruminant immunoinflammatory response.
The array is thus small and focussed, and can only provide information
about immunoinflammatory responses. The four types of samples were
analysed pairwise, and the array validated by the real-time RT-PCR
analysis of seven genes, picked on the basis of their differential
expression in multibacillary and paucibacillary ileum samples.
6.2 Microarray quality control
6.2.1 Heat Plot
A heat plot was produced for each channel on each array to check for
trends in intensity across the chip. Ideally, the high and low intensity
spots are uniformly distributed across the array, indicating that the
hybridisation was successful. Figure 6.1 shows an example of an array
with a uniform intensity. All of the arrays used in the analysis had R
values of less than 0.4.
6.2.2 MA plot
An MA (log ratios versus mean log intensities) plot was produced for each
array both before and after normalisation. Points on an MA plot from a
successful array should be in a cluster around 0 on the Y axis, as most
genes would be expected to have no differential expression. Usually, spots
of lower intensities are more spread out around 0, due to the background
subtraction method used by Bluefuse. After normalisation, the points
should be more linear and cluster more tightly together. MA plots can
thus be used to identify any unusual trends in the microarray data.
Figure 6.2 shows typical MA plots before and after normalisation. MA
plots for all of the arrays were produced and examined to ensure that the
arrays were hybridising as expected.
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6.2.3 Inter-array variation
Figure 6.3 shows boxplots of normalised ratios for all spots on one set of
six experiments, excluding blanks and buffer spots - these are the spots
that are used in all the subsequent analyses. For all sets of experiments,
the majority of the spots showed a similar distribution of values on all the
six chips so a further normalisation between arrays was not required.
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Figure 6.1: Heat map of channel 2 on 3P vs. 2C chip. Blue indicates low intensity and red
high intensity. The landing lights (bottom left of each block on the image) are clearly visible
as high intensity in most blocks. The high intensity spots are fairly uniformly distributed
across the chip with no apparent trends in intensity
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Figure 6.2: MA plots of 3P vs. 2C chip, (a) is a typical raw data MA plot. The points form a
curved line, with a 'fish-tail' effect towards the lower intensity end of the plot, (b) is a plot of
the same data after normalisation. The points now line up horizontally around 0 and the 'fish¬
tail' effect is no longer appreciable.
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Figure 6.3: Boxplot of one set of microarrays. Boxes represent the interquartile range of
ratios after normalisation, with the line representing the median, and the spots representing
outliers. The six arrays have similar interquartile ranges and distribution of values, indicating
that further normalisation would be unnecessary.
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6.3 Gene expression analysis
The design of the array analysis divided the 24 samples of interest into
groups of four, each containing one sample of each type. The four samples
in each group were compared pair wise with each other sample, utilising
six arrays. This was repeated for each group, using a total of 36 arrays.
The samples and comparisons used are given in table 6.1.
Of the 600 genes analysed on the array, 63 fulfilled the criteria of fold-
change greater than 1.5 and p<0.05 in at least one comparison.
Additional microarray data is provided in Appendix 3 (CD). These genes
and fold-changes are listed in Table 6.2. The fold-changes given are a
mean of all probes for each gene. Four genes were found to be
differentially expressed in infected samples compared to uninfected
controls, and a further eight in clinically affected samples compared to
uninfected controls. Eight genes - ANPEP, CD3E, CD3G, CD247, TRDC,
IGFBP3, IGHA1 and CCL2 - were differentially expressed in clinically
affected samples compared to asymptomatic samples.
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*M=multibacillary, P=paucibacillary, A=asymptomatic, C=control. Numbers represent
RNA sample numbers (Table 4.1)
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Table 6.2: Mean fold-changes of significantly differentially expressed genes. Bold denotes
genes selected for validation by real-time RT-PCR. Changes less than 1.5 were included to
show trends in the data.
Comparison
Gene A vs. C M vs. C P vs. C M vs. A P vs. A M vs. P
ANPEP 0.46 1.6 0.4 0.43
C3 1.42 1.75 1.53
C7 1.83 1.5
C9 1.69 2.1 0.62
CCL2 1.73 1.51 1.64 1.65*
CCL5 0.7 0.65 0.66
CCR7 0.68 0.58 0.71
CD247 0.75 0.52 0.64 0.69
CD3D 0.67 0.48 0.58
CD3E 0.73 0.55 0.63 0.63
CD3G 0.68 0.41 0.54 0.6
CD55 0.63 0.69
CD63 1.77 1.87 1.62
CD74 0.56 0.68 1.49
CD79A 0.47 0.41 0.52
CFB 1.71 1.52
CFH 1.38 1.83 1.43
CLIC5 0.62 0.65
CP 0.59* 0.65 0.77
CR2 0.34 0.34 0.43
CXCL10 2.31 2.25 0.58*
CXCR3 1.54
CXCR4 0.55 0.61 1.82 1.9
DEFBl 1.66 1.41 1.89
FCER1G 1.87 2.28* 1.49 2.28*
GAPDH 0.63
ICAM1 1.55 1.9 1.45 1.31
IGF2R 1.65 1.74 1.51
IGFBP3 0.6 0.58 0.64 0.62
IGHAl 1.85 1.96 1.85 1.96
IGHE 1.59 0.59* 0.69
IGHM 0.69 1.59 1.83 2.31
IGJ 1.47 2.38 1.89 0.62
IL16 0.67 0.59 0.65
IL18RAP 1.66 1.68
ITGA4 0.54 0.52 1.52 0.63
ITGAL 0.56 1.91 3.58 1.9 1.95
ITGAM 1.51
ITGB2 1.89 2.03 1.95
MHC class IIDQB1/2 0.64 1.36
MHC class II DQB1 0.66 0.57*
MHC class II DR A 0.65
MHC class II DR B1 0.63 0.64
MHC class II DYA 0.65 1.67
*Changes not statistically significant, but >1.5 fold
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Table 6.1 continued
Comparison
Gene A vs. C M vs. C P vs. C M vs. A P vs. A M vs. P
MHC class II DYB 1.63 1.5 1.48
MMP7 1.93 1.84
MMP9 1.47 1.98 1.76




SELL 1.98 1.85 1.58* 1.83*




TLR2 1.95 1.52 1.52
TNFRSF1B 1.6 1.62 1.5
TRDC 0.56 0.63
TFRC 2.65* 2.79 1.78 1.81*
TYROBP 1.9 1.95 1.68
VIM 1.56 1.48
'Changes not statistically significant, but >1.5 fold
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6.4 Real-time RT-PCR validation of Microarray results
Of the 63 genes found to be differentially expressed in the microarray
experiment, twelve were chosen for real-time RT-PCR validation -
MMP9, ITGB2, ICAM1, CD63, CXCL10, TYROBP, IGF2R, MMP7,
SLC11A1, OXT, TLR2 and TNFRSF1B. All of these genes were
differentially expressed in paucibacillary and multibacillary samples.
Primers were successfully designed and optimised for nine of the genes —
primers were designed for SLCllAl and TNFRSFlB but consistently
produced multiple products, and primers for CXCL10 could not be
optimised for use in real-time RT-PCR. A standard curve was produced
for each gene using serial dilutions of a cDNA pool of all samples. An
example of a typical standard curve is shown in Figure 6.4.
The remaining nine genes were analysed using real-time RT-PCR
analysis, and expressed as fold-changes relative to an arbitrary calibrator
sample. For all cases except OXT this was control sample 36. For OXT,
the calibrator sample was paucibacillary sample 3, as OXT was not
expressed in control or asymptomatic samples. The expression of MMP7
and CD54 was too low to be accurately quantified (fewer than 100
copies/reaction). The results of the real-time RT-PCR analysis confirmed
the results from the microarray experiment, with minor differences in the
magnitude of the fold-change, probably due to differences in sensitivity of
the two methods. In addition, several borderline significant changes in
the microarray results were significant in the real-time RT-PCR results..
Table 6.3 shows the results expressed as relative fold-changes in the six
comparisons, and Figures 6.5a-g shows the fold-changes in each gene
relative to a calibrator sample.
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Table 6.3: Relative fold-changes of genes analysed in real-time RT-PCR. Bold denotes
statistical significance.
Comparison




5.0 1.7 1.6 3.2 1.1 3.0




4.1 1.9 0.97 4.2 2.0 2.1




4.5 2.2 1.0 4.3 2.1 2.1




9.7 1.0 0.65 14.9 1.6 9.3









7.3 1.7 1.1 6.8 1.6 4.3




7.4 2.5 0.78 9.4 3.1 3.0
P-value 0.00 0.00 0.30 0.00 0.01 0.00
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Figure 6.4: Generation of cDNA standard curves for real-time PCR (a) Fluorescence
versus cycle number (time) graph for an acceptable standard curve - cDNA dilutions are
spaced two cycles apart and efficiency is between 0.9 and 1.1. Arrow indicates NTC. (b)
Standard curve taken from (a). All values are close to ideal, and points sit well on the line
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Multibacillary Paucibacillary Asymptomatic Control
Figure 6.5: Mean fold-change of genes compared to calibrator sample. Error bars
indicate the 95% confidence interval, (a) Shows the relative expression of CD63 (b) shows
the relative expression of IGF2R.
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Multibacillary Paucibacillary Asymptomatic Control
Figure 6.5 cont. (c) Shows the relative expression of ITGB2 (d) shows the relative
expression of MMP9.
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Multibacillary Paucibacillary Asymptomatic Control
Figure 6.5 cont. (e) Shows the relative expression of OXT. OXT expression in
asymptomatic and control samples was too low to be accurately quantified, (f) shows the
relative expression of TLR2.
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Multibacillary Paucibacillary Asymptomatic Control
Figure
cont. (g) Shows the relative expression of TYROBP
6.5
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The expression of all genes was significantly up-regulated in
multibacillary samples compared to each of the other groups. This agrees
well with the results of the microarray. CD63, IGF2R, ITGB2 and
TYROBP were found to be up-regulated in paucibacillary samples
compared to controls. All of these genes showed a slight up-regulation in
the microarray results, but this was below the selection criteria for
significant genes. CD63 was also found to be up-regulated in
asymptomatic samples compared to controls, contradicting the array
results which suggested that there was no change in the expression of
CD63. CD63 was the only gene to be up-regulated in all infected samples.
IGF2R, ITGB2, MMP9 and TYROBP were up-regulated in paucibacillary
samples compared to asymptomatic samples. Again, these genes were
slightly up-regulated in the microarray, but below the selection criteria.
6.5 Discussion
This study has analysed the expression of a selection of genes in the three
forms of paratuberculosis in sheep. Generally, the microarray results
showed that there is a massive change in expression of
immunoinflammatory genes in both paucibacillary and multibacillary
infection, with 24 and 34 genes found to be significantly differentially
expressed respectively. This was to be expected when the histopathology
results are taken into account, showing massive inflammation and
infiltration of immune cells to the site of infection. Perhaps less expected
were the 21 genes differentially expressed in asymptomatic samples
compared to controls, as the histopathology results for these samples
show no signs of infection or inflammation.
Seven genes were chosen, on the basis of differential expression in
multibacillary and paucibacillary samples, and their possible relation to
paratuberculosis pathology, to be validated using real-time RT-PCR. The
results of the real-time RT-PCR assays accuratly reflected the results of
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the microarray analysis. This firstly validates the microarray results and
demonstrates consistency. Secondly, it gives a greater understanding of
the differential expression of this selected group of genes.
The seven genes studied — CD63, IGF2R, ITGB2, MMP9, OXT, TLR2 and
TYROBP — were all significantly up-regulated in multibacillary samples
compared to all others, which was consistent with the microarray results.
The real-time results differed from the microarray results in
paucibacillary samples. Compared to control samples, CD63, IGF2R,
ITGB2 and TYROBP were up-regulated in paucibacillary samples, results
not reflected in the filtered microarray data. However, when the
unfiltered normalised data were examined, it was found that these
changes were evident in the microarray data, but they were below the
cut-off criteria. Although the microarray results were well validated by
the real-time RT-PCR analysis, none of the genes successfully quantified
was significantly down-regulated in any comparison. Therefore, the
validation does not fully reflect the range of fold-changes observed in the
array data, and in future could be improved by either including more
genes or picking genes at random for validation.
The array results did not, however, fully reflect the results of the previous
real-time studies. Only CXCR4 was found to be significantly differently
expressed in the array data. There are several reasons for the apparent
discrepancy. The oligo for TRAFl was designed using human sequence
and thus may not have bound ovine TRAFl with high affinity. The
microarray is less sensitive than real-time PCR, as demonstrated by the
differences in fold-change between the microarray and real-time
validation results. Finally, the chosen method of analysis and
normalisation for these arrays detected only those genes stably expressed
across six comparisons. As many of the genes previously quantified were
highly variable, these would not be detected by the microarray analysis.
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Many of the genes found to be differentially expressed in the microarray
and real-time RT-PCR analyses can be grouped together into different
immune pathways, allowing a comparison of the pathways involved in the
three different pathologies. This allows a more 'systems biology' approach
to be taken in the analysis of these results, giving a more in depth picture
of the pathologies.
Both paucibacillary and multibacillary samples displayed significant up-
regulation of FCERG1, which may indicate up-regulation of the FCERGl
signalling pathway. This pathway is activated by IGHE, which is slightly
up-regulated in these samples, but not significantly so. Activation of the
FCER1G signalling pathway can lead to activation of the phosphatidyl
inositol and MAPK signalling pathways, which in turn lead to production
of cytokines including TNFa, which is up-regulated in both types of
sample, and CSF2, which is up-regulated in paucibacillary samples.
Although asymptomatic samples show a significant up-regulation of
IGHE, the corresponding up-regulation of FCERlG was not observed.
Compared to asymptomatic samples, both multibacillary and
paucibacillary show significant up-regulation of STAT1, as well as
cytokines that activate the JAK-STAT signalling pathway including IL6
and TFNG. Activation of the JAK-STAT pathway leads to activation of
genes involved in the activation of lymphocyte subsets. STAT1 is slightly,
but not significantly, up-regulated in these samples compared to controls.
It is therefore likely that activation of the JAK-STAT pathway is a
significant step in the development of clinical paratuberculosis.
TLR2 was greatly up-regulated in multibacillary samples compared to all
other groups, suggesting that the TLR2 signalling pathway is important
in multibacillary pathogenesis. TLR2 is central to the immune response
to mycobacteria — knockout mice are significantly more susceptible to
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mycobacterial infections (243). In leprosy in humans, TLR2 signalling can
alter the cytokine responses. Studies in monocytes with a TLR2 mutation
have shown that normal TLR2 signalling leads to a type 1 response,
whereas signalling through the mutated TLR2 leads to increased IL10
production and a type 2 immune response (124). A recent study in bovine
monocytes infected with MAP has shown that TLR2 signalling is involved
in phagosome trafficking and anti-microbial responses through the
MAPK pathway (270). TLR2 acts a dimer with either TLRl or TLR6. The
expression of both of these genes was not significantly different in the
microarray, contradicting the suggestion that TLR2 signalling is
activated. However, the probes for both TLRl and TLR6 were designed
using human sequences, which may have affected the binding of the ovine
cDNA to the probe, and thus the data may be unreliable. The TLR2 probe
was designed using bovine sequence.
If a ligand is bound to TLR2, this can activate a series of TLR regulatory
molecules. Both paucibacillary and multibacillary samples have displayed
down-regulation of TIRAP, which acts as a co-regulator with MyD88.
These data suggests that a MyD88"independent pathway is utilised in
clinical paratuberculosis to regulate the activity of TLRs. The TLR
signalling pathway leads to production of proinflammatory and
chemotatic cytokines, both of which are up-regulated in clinical
paratuberculosis.
All samples infected with MAP displayed down-regulation of several
genes encoding elements of the T-cell receptor complex - CD3E, CD3D,
CD247, and CD3G -and other genes involved in the TCR signalling
pathway, including CR2 and PTPRC. The TCR signalling pathway has
many functions, and can lead to activation and differentiation of T cells, T
cell cytotoxicity and T helper cell functions, and the production of a host
of cytokines, including IFNG and IL10. These TCR molecules are also
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markers of various T cell subsets. As this response is seen in all infected
samples, it is possible that this down-regulation is caused by infection by
the mycobacteria, and may represent a method of host response
modification by the mycobacteria.
The expression of several genes involved in leukocyte transendothelial
migration, including ITGAL, ITGB2, ICAM1, CXCR4 and MMPs were up-
regulated in multibacillary samples. The expression of these genes was
either unchanged or down-regulated in asymptomatic and paucibacillary
samples. This suggests that even at a late stage in the disease there are
still a large number of leukocytes entering the site of infection in
multibacillary animals. This agrees with the histopathological
observations that the ileal tissue contains large numbers of macrophages.
Up-regulation of both CXCR4 and MMP9 has previously been reported in
bovine macrophages in response to MAP stimulation (117,158).
The results of the microarray suggest strongly that NK cell cytotoxicity is
involved in paratuberculosis pathogenesis. Several genes involved in
cytokine production and release by NK cells are up-regulated in
multibacillary and paucibacillary samples, including ITGAL, FCER1G
and TYROBP, as well as the cytokines themselves. However, there is no
evidence from the array that this leads on to the synthesis of products
such as FASL and perforin via the JAK'STAT pathway, which can lead to
the initiation of apoptosis in an affected cell.
All infected samples displayed up-regulation of some elements of the
complement cascade. These genes include C3 and C7 in multibacillary
samples, CFB, CFH and C9 in paucibacillary and CFH and C9 in
asymptomatic samples. The up-regulation of CFB suggests that, in
paucibacillary and asymptomatic samples, the alternative complement
pathway is activated. This would lead to production of the membrane
attack complex and cell lysis, which would in turn lead to further
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inflammation at the site of infection. However, the upregulation of CFH
in these samples also suggests that the complement cascade is being
controlled.
In both asymptomatic and multibacillary samples there is a general
down-regulation of MHC class II and associated genes, including CD74,
which is not observed in paucibacillary samples. This down-regulation
would lead to lower levels of CD4 cell activation. As these cells are
responsible for the activation of both cell-mediated and humoral acquired
immune responses, this lack of activation would lead to a reduction in
activation of the whole acquired immune response. The results agree with
previous studies which have identified a reduction ofMHC class II
expression in paratuberculosis, which is thought to be due to
mycobacteria-mediated modulation of the immune response
(5,215,253,267).
Several of the genes found to be differentially expressed in the microarray
and real-time RT-PCR results could not be easily classified into
biologically functional pathways. Of these genes, five were differentially
expressed in all infected samples - CD63 and DEFB1 were up-regulated,
and CD79a, CP and IL16 were down-regulated. CD63 is a tetraspanin
thought to complex with integrins and keep them clustered on the cell
surface and DEFB1 is an anti-microbial peptide involved in the resistance
of epithelial surfaces to colonisation. The up-regulation of these genes
may simply reflect the immune activation already evident in this tissue.
The down-regulation of CD79a, part of the B-cell receptor complex, may
reflect a reduction in the number of B-cells present in the tissues. The
down-regulation of CP, a copper carrying enzyme indicative of the acute
phase response, and IL16, a chemoattractant and modulator of T-cell
activation, further reflects a 'damping down' of the immune response,
possibly related to the late stage of infection of these samples.
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In addition, four genes were differentially expressed only in clinically
affected sheep - IGF2R, IGHAl and IGJ were up-regulated and IGFBP3
was down-regulated. IGHAl and IGJ combine to form dimeric IgA, a
secreted antibody produced by B cells. These results are supported by the
antibody ELISA results, but is confused by the down-regulation of CD79a,
which suggested either a reduction in activation of B cells, or a reduction
in the number of B cells present, both of which should lead to a reduction
in the amount of IgA produced. IGF2R was also up-regulated. IGF2R is a
receptor for IGF2 and M6P. It plays a role in the activation of TGF6, a
gene shown to be up-regulated in these samples in the previous real-time
RT-PCR study. IGFBP3 has similar functions to IGFBP6, discussed in
detail in Chapter five, and its role in the immune system is unknown.
Paucibacillary and asymptomatic samples both displayed differentially
expressed IGHM, which was up-regulated in paucibacillary samples and
down-regulated in asymptomatic samples. IGHE was also up-regulated in
both paucibacillary and asymptomatic samples, although this was not
significant in the paucibacillary samples. As previously discussed, IGHAl
was also up-regulated in paucibacillary samples, as was PIGR, a
component of the immunoglobulin secretory pathway. These results taken
together suggest that either the types of antibody expressed in the three
pathologies may have an effect on disease progression, or simply that
they are reflective of the type of disease that has developed. These results
also contradict the antibody ELISA results described in Chapter 3, which
state that most of the paucibacillary animals did not produce MAP
specific antibodies.
Finally, there was a group of genes differentially expressed in only one of
the three pathologies studied. In the asymptomatic samples, GAPDH and
SIRPA were down-regulated and STS was up-regulated. These genes are
not thought to be involved in the immune response, and are concerned
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with normal cellular functions, growth and differentiation. The role of
any of these genes in establishing asymptomatic paratuberculosis is
unclear. In paucibacillary samples, IL18RAP and PI3 were up-regulated.
IL18RAP is a subunit of the IL18 receptor and is required for the
activation of the NFKB and MAPK8 pathways in response to IL18. As
previously shown, IL18 is down-regulated in these samples. The up-
regulation of the IL18 receptor may be an attempt to increase the
sensitivity of the cell to low levels of IL18 at this late stage of the disease.
PI3 is a serine antiprotease with anti-inflammatory effects in neutrophils.
The expression of this gene has been linked to inflamed ulcerative colitis
and may act to reduce tissue damage in the intestine (200). OXT, TFRC,
VIM, SLC11A1 and SELL were up-regulated in multibacillary samples.
OXT is a hormone involved in pregnancy and maternal behaviour,
normally expressed in the pituitary gland. Which cells could be
expressing OXT in the ileum and what role it is playing in multibacillary
pathology are unknown. TFRC is involved in iron transport from the
intestine to the rest of the body and has been previously shown to be up-
regulated early in MAP infection in cattle (277), and VIM is a cytoskeletal
element. Again, the role of these genes in multibacillary pathology is
unclear. SLC11A1 functions as a divalent metal transporter and has
been linked to susceptibility to Crohn's disease (44,205). SELL is a
lymphocyte adhesion molecule. Previous studies ofM.bovis infected deer
have found up-regulation of SELL in infected lymph nodes. As effector
CD4+ cells express low levels of SELL, it was suggested that up-
regulation of SELL could lead to lower levels of macrophage activation
(85).
Overall, this microarray study has identified several genes and pathways
which warrant future investigation.
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Chapter 7: Discussion and conclusions
136
CHAPTER 7 DISCUSSION AND CONCLUSIONS
7.1 Discussion
Paratuberculosis is a chronic inflammatory disease of the gut of
ruminants, caused by infection with MAP and characterised by
granulomatous enterocolitis, lymphangitis and lymphadenitis (52). It has
a global distribution, with the herd level prevalence in cattle ranging
from 0% to 71% (155). It is a major problem for livestock producers. Cows
with clinical paratuberculosis produce 19.5% less milk and those with
sub-clinical paratuberculosis produce 16% less milk (24).
Paratuberculosis in livestock may also have an impact on human health,
with a recent study concluding that current evidence strongly supports a
causal relationship between MAP and CD (251).
Detecting infection with MAP before the onset of clinical symptoms, and
the associated bacterial shedding, is problematic, and the most cost-
effective way of preventing Johne's is by vaccination. The current
Gudair™ vaccine is a whole cell preparation of heat-killed MAP which
can offer some protection against shedding and mortality (114). However,
of the few vaccinated sheep that do go on to develop paratuberculosis, all
have the multibacillary form of the disease (185,274).
Once within the macrophage, MAP can prevent the maturation of the
macrophage phagosome and may survive in these for several weeks
(12,230,252). To do this, the mycobacteria prevent bacterial killing
through several mechanisms (230). Antibodies are produced by all
animals with multibacillary disease, but only some animals with
paucibacillary disease (35,136). In sheep the T cell response is polarised
and leads to the observed differences in pathology (36,144,224).
Few studies have been carried out on the expression profiles of sheep
infected with MAP, perhaps assuming that the profiles would be similar
to those seen in cattle. Overall, little is known about gene expression in
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ovine paratuberculosis, and there have been no extensive microarray
studies done in this area.
This study aimed to address several of the current concerns about
paratuberculosis in sheep. Quantification of the gene expression profiles
of sheep with the different pathologies provides a greater understanding
of the differences in immune response in these sheep. This in turn may
aid the understanding of T cell polarisation and how best to produce a
successful response to paratuberculosis vaccine in sheep, and may give
insights into other inflammatory bowel diseases, including Crohn's
disease in humans.
In order to perform differential gene expression studies accurately, it was
first essential to define unambiguously the three pathological forms of
paratuberculosis in both histopathological and molecular terms. It was
confirmed that the forms of the disease are similar to human leprosy
where the pathology can be differentiated into tuberculoid
(paucibacillary), lepromatous (multibacillary) and asymptomatic (infected
but no pathology) (53). As with ovine paratuberculosis, the tuberculoid
form of the disease has lesions formed of infiltrating T cells and contain
few bacteria; and the lepromatous form has lesions of infiltrating
macrophages containing large numbers of bacteria (164).
The differences between multibacillary and paucibacillary pathologies
were easily defined in terms of pathology, but were more ambiguous in
individual molecular tests. However, this work has provided the first
unambiguous definition of asymptomatic sheep, as having normal ileal
histology but being infected with MAP as shown by detection of IS900 by
real-time RT-PCR of both ileum and mesenteric lymph node tissues.
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These results form the foundation of a robust and useful definition of the
three forms of paratuberculosis in sheep and as such will be useful for
any future work on paratuberculosis in sheep. In future studies, it would
be useful to analysis the cell populations present in these tissues by
FACS or immunohistochemistry of the tissue sections. Although the
histopathology results clearly show that, for example, there are more
macrophages in multibacillary tissue than in paucibacillary tissue, it
would nonetheless be helpful to know the relative population sizes of
rarer cells, such as eosinophils and NK cells, and apply this knowledge to
the gene expression data. A recent study in infected cattle revealed that
the regulatory T cell population is expanded in the ileum and could be
responsible for suppression of the immune response (268), therefore
investigating the relative populations of T cells in these sheep could be
valuable. A second avenue for future work in this area would be to look at
ELISA score cut-offs in relation to paucibacillary animals. It was
observed that paucibacillary animals had higher ELISA scores than
asymptomatic animals, even when all were classed as negative as defined
by the manufacturer. It would be of value to investigate whether this is
the case in younger animals, and could form the basis of an ELISA test
able to predict what type of disease is likely to develop.
The second stage of this study looked at the differential expression of a
panel of cytokine and non-cytokine genes in ovine paratuberculosis.
Despite a large variation in the levels of cytokine transcript expression,
the study showed unambiguously that there is a relationship between the
three pathological forms of sheep paratuberculosis and cytokine
transcript profiles. Secondly, the study confirmed, as has been shown
with bovine paratuberculosis (63,138,242), that the paucibacillary and
multibacillary forms of the sheep disease are associated with the
polarization of the immune response and that polarised Thl and Th2 cells
are associated with paucibacillary and multibacillary pathologies
139
CHAPTER 7 DISCUSSION AND CONCLUSIONS
respectively, when compared to asymptomatic animals. Lastly, these
results highlighted that, although the pathologies are associated with
immune polarisation, this is not a clear cut difference, with upregulation
of the anti-inflammatory cytokine TGF13 and IFNy in both disease types
when compared to control animals.
The gene expression analysis of non-cytokine genes revealed several
genes differentially expressed in asymptomatic samples compared to
controls, which, when combined with the cytokine gene data, may point
towards what constitutes a successful response to MAP infection. This
analysis also identified two non-cytokine genes that are differentially
expressed in paucibacillary and multibacillary samples and thus may
have an impact on what type of disease develops. These genes — CXCR4
and IGFBP6 — were analysed by SNP analysis. However, there was no
association between 5 of the 6 SNPs and pathological type. Only the
coding region of each gene was analysed in this study, so it may be of
value to expand this analysis to include the upstream promoter regions of
each gene, as SNPs in this area may be more likely to affect gene
expression. A sixth SNP, found in the IGFBP-6 gene, was only found in
clinical samples. However, the SNP was only found in 3 out of 20 clinical
samples. It may therefore be of value in the future to analyse a large
number of sheep to see if any association exists.
Although these studies represent a robust and reproducible
quantification of cytokines involved in paratuberculosis pathologies, the
method does have several drawbacks. In future it may be more valid to
use a cDNA curve, instead of pDNA standards. Also, although absolute
quantitation is useful, the copy numbers produced are still relative to the
amount of starting material and to the reference gene, and it may thus
improve such studies to use a more robust method incorporating relative
quantitation.
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Preliminary, non-statistical analysis of the relative worm burden in these
sheep would suggest that a higher FEC is associated with the
development of multibacillary disease and a lower worm burden is
associated with development of paucibacillary disease. As animals with
both types of disease have inflammation of the intestine, it is unlikely
that this is the cause of the higher FEC in multibacillary animals. Having
confirmed that the different pathologies are associated with immune
response polarisation, future studies could address whether these higher
worm burdens are skewing these responses towards a Th2 response, and
thus multibacillary paratuberculosis, and whether better control of worm
burden in sheep could reduce incidence of multibacillary disease.
The final part of this study involved carrying out the first extensive
microarray study on paratuberculosis in sheep. The study identified 63
genes differentially expressed in the different types of disease, with 24, 34
and 21 genes found to be significantly differentially expressed in
paucibacillary, multibacillary and asymptomatic samples respectively
when compared to controls. 16 genes were identified as differentially
expressed in paucibacillary and multibacillary samples. These results
were well validated and then used to carry out pathway analysis. This
analysis identified several pathways of interest. MAP regulation of the
immune response was confirmed, with down-regulation of both MHC
molecules and TLR signalling pathways. In addition, several novel
pathways were identified for future analysis.
This study was performed using a small focussed array. Compared to a
larger array, it. was easier to analyse, and more detailed quality control
was carried out, reducing the possibility of false positive results. It was
also oligo-based, allowing rapid identification of the genes. However,
although the results from the array study were robust and interesting,
the study had certain limitations. The array concentrates on genes likely
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to be involved in immunoinflammatory responses. This introduces
problems when the array is used to quantify gene expression in
immunoinflammatory diseases, because any change in gene expression
will seem relevant to the observed pathology. This false discovery rate is
accounted for when the data are normalised, but can be higher than for a
less focussed array. The small number of genes analysed on the array also
introduces difficulties when carrying the pathway analysis, as commonly
only two or three genes from any pathway are represented. Finally, the
low sensitivity of the array may lead to a loss of valuable data, as
demonstrated by the lack of reproducibility of the real-time results in the
array analysis.
Further microarray work on these samples using a large, less focussed
array could provide more insights into the immune responses in the
different pathologies. A larger array would allow a more extensive
systems biology approach to be taken, by including more genes and
providing the link between genes involved in the immune response as
well as other cellular processes.
7.2 Conclusions
Sheep paratuberculosis is not a spectrum of disease but three distinct
pathologies. We produced the first unambiguous definition of these
pathologies in both pathological and molecular terms, and revealed that
asymptomatic animals are infected and can be distinguished, in terms of
cytokine gene expression pattern, from uninfected controls.
The expression level of several cytokine and cytokine related genes in the
three forms of ovine paratuberculosis were quantified using real-time
PCR analyses and confirmed that sheep pauci- and multibacillary disease
are linked to type 1 and type 2 T cell responses respectively, although the
pathologies are not as polarised as expected. The expression patterns of
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other cytokines shows that both disease forms have an inflammatory
aetiology. The central role for ILrla in bovine paratuberculosis is not seen
in the sheep infection.
We characterised the expression of a panel of non-cytokine genes,
revealing several genes differentially expressed in asymptomatic samples
compared to controls, which, when combined with the cytokine gene data,
point towards what constitutes a controlled response to MAP infection.
This analysis identified two non-cytokine genes differentially expressed
in paucibacillary and multibacillary samples. Analysis of the sequence of
these genes, CXCR4 and IGFBP6, revealed that there is no link between
the coding regions and which paratuberculosis pathology develops.
Microarray analysis of the expression of a number of
immunoinflammatory genes revealed that, although 63 genes are
differentially expressed in the different types of disease, there is no
definitive molecular signature for paratuberculosis pathologies. Using
these data for pathway analysis identified novel pathways for future
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Abstract
Background: Johne's disease is a chronic inflammatory disease of the gut caused by infection with
Mycobacterium avium subspecies paratuberculosis (MAP). Symptoms include wasting, diarrhoea, loss
of condition and eventual death. Three forms of Johne's disease have been described in sheep -
paucibacillary, multibacillary and asymptomatic. The paucibacillary form is characterized by an
inflammatory, Thl-type immune response. The multibacillary form of the disease, which
disseminates the infection, is characterized by macrophage infiltration mediated by a Th2-type
immune response, and asymptomatic animals have no clinical symptoms or pathology but are
infected with MAP. What determines these three forms of the disease is unknown. To further
understand these differences, we used real-time RT-PCR to compare the expression of thirteen
cytokine and cytokine-related genes in ileal tissue from sheep with the three forms of the disease.
Results: Three pathological forms of sheep paratuberculosis were defined on the basis of
histopathology, cytochemistry (Zeihi-Neelsen) and IS900 PCR. Paucibaciilary lesions have largely T
cell and eosinophil infiltration and are ZN negative; multibacillary lesions have macrophage
infiltration and large numbers of acid-fast bacteria. The pauci- and multibacillary forms are linked
to the differential expression of IFNy and IL-10 respectively. In addition the increased levels of the
proinflammatory cytokines (IL-1 p and TNFa), IL-8, IL-18 and TRAF-I in both diseased forms is
indicative of persistent inflammatory lesions. No changes were seen in IL-la in any sheep ileum
tissues. Asymptomatic animals are IS900+ with normal histology but have significantly decreased
levels of IL-18 and increased levels TNFa.
Conclusion: We have quantified the expression levels of thirteen cytokine and cytokine related
genes in three forms of ovine paratuberculosis using real-time PCR analyses and confirm that sheep
pauci- and multibacillary disease are linked to type I and type 2 T cell responses respectively. The
expression patterns of other cytokines shows that both disease forms have an inflammatory
aetiology but that the central role for IL-la in bovine paratuberculosis is not seen in the sheep
infection. Asymptomatic animals are infected and show no pathology but can be distinguished, in
terms of cytokine expression pattern, from uninfected controls.
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Background
Paratuberculosis (Johne's disease) is a chronic intestinal
disease of ruminants caused by the bacterium Mycobacte¬
rium avium subspecies paratuberculosis. The disease is
responsible for extensive economic losses worldwide
related to fatality and loss of productivity [1,2]. The route
of disease transmission is mainly faecal-oral; and
neonates, when not infected congenitally are infected by
ingestion of bacteria from infected teats or the pasture
transmitted via the dissemination of diarrhoea from
infected animals |3[. Consequently the majority of ani¬
mals within an infected herd or flock become infected |3[.
However, in sheep infection can give rise to three different
forms of disease with only about 30% of animals in an
infected flock becoming clinically affected. The majority
of animals are asymptomatic; they are infected but show
no pathology and do not develop clinical disease [4|. The
remaining clinically-affected sheep show two distinct
forms of the disease. Approximately 30% of disease cases
are affected by the paucibacillary form of lohne's disease;
they have very few bacteria and show a T cell infiltration
into the gut. About 70% of cases have the multibacillary
form, which is characterized by a high level of bacterial
infection and a macrophage and B cell infiltration into the
gut lamina propria. Both the pauci- and multibacillary
forms are equally fatal but there is no evidence that the
asymptomatic animals ever succumb to disease [4,51.
lohne's disease pathogenesis in cattle may differ from that
in sheep as it is presumed that there is disease progression
from the asymptomatic to paucibacillary and then to die
fatal multibacillary form [6|. However, even in cattle 4-
11% of animals in affected herds are infected but only 2-
4% develop the disease [7,8|. Like the two other major
mycobacterial diseases, tuberculosis and leprosy, the epi¬
demiology of paratuberculosis suggests a genetic suscepti¬
bility [9|. The paucibacillary cases (tuberculoid
pathology) tend to have a strong cell-mediated immunity
(CMI), high levels oflFNyand IL-2 and low levels of anti¬
body [10-12]; the multibacillary cases (lepromatous
pathology) have high antibody and pro-inflammatory
cytokine levels and weak CMI J 10,12). Little is known
about the asymptomatic form although they are positive
for bacterial growth, IS900 and specific antibody [13,14].
As with tuberculosis and leprosy it seems clear that the
polarization of the immune response is critical to the clin¬
ical outcome of the paratuberculosis infection [15-17],
The intestinal tissue damage that results from a Thl
response (paucibacillary disease) is fundamentally differ¬
ent to that caused by a Th2 response, which leads to multi
bacillary disease and dissemination of infection. The
polarization of the immune response is controlled by the
differential expression ofT cell polarizing cytokines [ 18J
and it seems that there is differential expression of some
of these cytokines in lohne's disease 119]. Several studies
describe the changes in expression of cytokines in periph¬
eral blood cells in cattle [20,211 and ileal tissue of both
sheep [ 11,12] and cattle [19,21-24]. Burrells el al. (1999)
[11] examined IL-2 and IFNy in both pauci- and multi¬
bacillary forms but not the asymptomatic animals while
Tanaka et al. [ 191 quantified cytokines in granulomatous
lesions during the preclinical stages of disease; all other
studies on the target organ concentrated on analysis of the
multibacillary form, including all studies on the ileal tis¬
sue in cattle.
This study tested the hypothesis that expression levels of a
panel of thirteen cytokine and cytokine associated genes
would be different at the site of infection in the three
forms of sheep paratuberculosis, and that these differ¬
ences could relate to the observed pathologies. Further¬
more, this study also analyses the asymptomatic form of




All animals from the Johne's disease infected flocks were
identified as IS900 positive by PCR analysis and therefore
judged to be infected with MAP. Three groups of 1S900+
animals could be discriminated on the basis of gross
pathology, ZN staining and histopathology. The asympto¬
matic group had no clinical signs or lesions consistent
with Johne's disease, at post mortem. Examination of his¬
tological sections of the terminal ileum showed normal
histology and no evidence of the presence ofacid-fast bac¬
teria (ZN-) (Figure 1A-1C). All other sheep showed clini¬
cal signs and post mortem lesions consistent with lohne's
disease and could be further differentiated into two
groups (paucibacillary and multibacillary) on the basis of
ZN staining ofhistological sections of terminal ileum. The
paucibacillary sheep had no detectable ZN+ bacteria (Fig¬
ure 2A) and showed a mixed inflammatory infiltrate into
the lamina propria (Figure 2B) comprising lymphocytes,
eosinophils and multinucleate giant cells (arrowed) with
fewer macrophages (Figure 2C). The multibacillary sheep
had high numbers of ZN+ acid-fast bacteria (Figure 3A),
mostly within the cytoplasm of the large numbers of epi¬
thelioid macrophages, which distend the lamina propria
(Figure 3B and 3C) and result in flattening of the surface
mucosa (Figure 3B). A fourth group of unrelated, control
sheep were IS900 negative and were judged to be unin¬
fected with MAP.
Gene expression analysis in ileal tissues
The expression levels of cytokine transcripts in sheep
ileum from the three groups of paratuberculosis-infected
sheep and in uninfected controls is shown in Table 1
which shows transcript copy number in relation to the
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Figure I
Histopathology of the terminal ileum from asympto¬
matic sheep, (a) Ziehl-Neelsen stain for acid-fast bacteria
(x 250) showing the absence of mycobacteria, (b) H&E
stained low power (*250) and (c) high power (*400) show
normal histology.
two housekeeping genes, GAPDH and SD1IA. These data
show that different cytokines are present at very different
levels in ileal tissue, varying from less than 100 copies
(e.g. IL-3) to greater than 100,000 copies (e.g. 1L-8 and IL-
10). They also show that levels of individual cytokine
transcripts show a high variability between animals, even
within the same pathological group.
Furthermore, it shows that individual cytokines are differ¬
entially expressed in the distinct disease states.
Ihis is more clearly shown in Figures 4 and 5 where the
results are expressed as statistically significant (p = 0.05)
fold change where data are compared in six pairs - pauci-
bacillary vs asymptomatic, multibacillary vs asympto¬
matic, paucibacillary vs multibacillary (Figure 4),
paucibacillary vs control, multibacillary vs control and
asymptomatic vs control (Figure 5). The expression levels
of two genes, IL-la and GM-CSF was relatively consistent
in all the animals regardless of disease status.
Figure 4 shows the comparison of cytokine transcripts
between the three infected groups of sheep. When the two
diseased forms were compared with the asymptomatic
samples TRAF-1, Il.-ip, 1L-6, IL-18 and IFNy were signifi¬
cantly up-regulated in paucibacillary ileum, (Figure 4a)
and TRAF-1, IL-10, IL-18, TNFa and TGFP were up-regu¬
lated in multibacillary samples (Figure 4b). Comparison
of the pauci- and multibacillary forms showed that only
IT-10 was significantly different, with the expression levels
in the paucibacillary ileum being approximately half that
in multibacillary tissue. In contrast the level of IFNy and
TRAF-1 were much higher in paucibacillary tissue, how¬
ever neither was quite significant (p = 0.057 and 0.062
respectively). If one outlier point in the TRAF-1 data was
removed from the ten samples the significance level was
increased to p = 0.02 (Figure 4c).
Figure 5 shows the comparison of cytokine transcripts
between the three infected groups and the uninfected con¬
trol animals. TRAF-1, IL-8, Il.-12p40, IFNy, TNFa and
TGFP were significantly increased in paucibacillary sam¬
ples (Figure 5a). The multibacillaiy sheep showed signifi¬
cantly increased levels of TRAF-1, II.-8, IFNy, TNFa and
TGFP (Figure 5b). The multibacillary ileum also showed
increased levels of IL-12p40 but this was not quite statis¬
tically significant (p = 0.06). Interestingly there were sig¬
nificant differences between the asymptomatic and
uninfected control samples, which showed that IL-18 was
down-regulated and TNFa was up-regulated in the asymp¬
tomatic sheep. IL-3 was detected at low levels in all
infected animals but never in uninfected control samples;
therefore it was not possible to produce fold-change fig¬
ures for these comparisons. Nevertheless, IL-3 was statisti¬
cally significantly up-regulated (p = 0.05) in both
multibacillary and asymptomatic samples (but not pauci¬
bacillary sheep) compared to controls, using the non-par¬
ametric Mann-Whitney test.
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Figure 2
Histopathology of the terminal ileum from pauci-
bacillary sheep, (a) Ziehl-Neelsen stain (x 250) showing
the absence of mycobacteria, (b) H&E stained low power
(*250) showing mixed inflammatory infiltrate into lamina
propria comprising lymphocytes, eosinophils, macrophages
and multinucleate giant cells, (c) H&E stained high power
(*400) showing multinucleate giant cells (large arrow) adja¬
cent to a crypt. There is an associated proprial inflammatory
reaction dominated by lymphocytes and eosinophils (small
arrows).
Discussion
The three major mycobacterial diseases of mammals -
tuberculosis, leprosy and paratuberculosis affect different
organ systems but share at least two important character¬
istics. Firstly, not all infected individuals become clinically
affected and second, there are at least two pathological
forms of each disease |2,25,26]. This is most obvious in
human leprosy where, although there is a spectrum ofdis¬
ease, the majority ofpatients are at either end of that spec¬
trum 1271. The tuberculoid form of the disease has lesions
formed of infiltratingT cells and contain few bacteria; and
the lepromatous form has lesions of infiltrating macro¬
phages containing large numbers of bacteria [27,28|. The
pathological picture of ruminant paratuberculosis seems
to mimic human leprosy |29| although this is most true of
the disease in sheep where the pathology can be differen¬
tiated into tuberculoid (paucibacillary), lepromatous
(multibacillary) and asymptomatic (infected but no
pathology) [ 11. There is a difference between these two
diseases however as the sheep tuberculoid form is an end
stage disease [5| and it is not self curing' as it is in leprosy
[27], "lhere also seem to be differences between ovine and
bovine paratuberculosis, as in cattle the pathological form
seems to be related to the disease development |6,29|,
with early stage tuberculoid lesions developing into end-
stage lepromatous disease. In addition, intermediate
stages between these two extremes have also been
reported [30,3 lj. Similar disease patterns are also
observed in tuberculosis, but as with bovine paratubercu¬
losis they seem to be more variable than leprosy [32].
Immunological responses to infectious disease challenge
have a major bearing on the clinical manifestations of that
infection and the clinical consequence for the host. This is
most obvious in human leprosy [33,34] where the type 1
T cell cytokine pattern predominates in the self-curing
tuberculoid patients in contrast to the type 2 pattern in
malign lepromatous disease. The aim of this present study
is to try and understand the relationship between the
immunology and the different pathological changes that
occur as a result ofMycobacterium avium subspecies paratu-
berculosis infection in sheep.
Despite the fact that there is a laige variation in the levels
of cytokine transcript expression, this study shows unam¬
biguously that there is a relationship between the three
pathological forms of sheep paratuberculosis and the
immune response as represented by the cytokine tran
script profiles within the target tissue. The large variation
is probably due to the fact that these sheep are unrelated,
of different breeds and are infected naturally rather than
experimentally; in addition they carry an unquantified
gastrointestinal worm burden that might influence ileal
cytokine expression. We cannot measure levels of func¬
tional protein for all the cytokines within the ileum but
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Figure 4
Statistically significant changes in genes between the
three IS900+ groups, (a) Comparison of paucibacillary and
asymptomatic; (b) comparison of multibacillary and asympto¬
matic; (c) comparison of paucibacillary and multibacillary.
Results are given as significant (p < 0.05) fold-changes of
mean copy-numbers relative to the mean copy-numbers of
the comparative group. IL-3 was not included, as the copy
number in the control samples was 0, thus fold change values
could not be calculated. The data for TRAF-1, highlighted
with * in (c) excludes a single oudier in the ten data (joints; p
= 0.062 with the outlier; p < 0.02 without the outlier.
Figure 3
Histopathology of the terminal ileum from multi¬
bacillary sheep, (a) Ziehl-Neelsen stain (* 250) showing
the presence of many intracellular mycobacteria associated
with the infiltrating macrophages, (b) H&E stained low power
(*250) showing infiltration of the lamina propria by sheets of
epithelioid macrophages distending the propria and flattening
the surface mucosa, (c) H&E stained high power (*400) dem¬
onstrating the uniform population of epithelioid macrophages
with abundant cytoplasm infiltrating around an intestinal
crypt.
assume that the relative quantities ofcytokine protein and
transcript aie linked.
As has been shown with bovine paratuberculosis 119-21 J,
the paucibacillary and multibacillary forms of the sheep
disease are also associated with the polarization of the
immune response. The comparison of each form of the
disease with tissue from asymptomatic animals shows
that IFNy is significantly increased in the paucibacillary
lesions and IL-10 is raised in the multibacillary form. Fur¬
thermore, direct comparison of the diseased tissues shows
that these two cytokines are reciprocally expressed.
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Table I: Cytokine transcript levels in terminal ileum from sheep with paratuberculosis infected sheep and controls
Gene Multibacillary Paucibacillary Asymptomatic Control
IL-la 69' ± 56 38 ± 14 51 ±42 20 ± 8
IL-ip 30839 ±41353 16470 ±8559 4176 ± 2557 8613 ± 6090
IL-3 29 ±74 1 ±3 87 ± 131 0±0
IL-6 71778 ± 124310 11023 ±2980 4996 ± 1698 5473 ± 7583
IL-8 1448098 ± 1453346 609805 ±511880 480573 ± 601312 150388 ±59472
IL-IO 305964 ± 127868 174186 ± 82536 126941 ±94659 240619 ± 185599
IL-12 7178 ±7381 7589 ± 6467 4506 ±5179 1615 + 2436
IL-18 102838 ± 45161 84037 ± 34888 42352 ± 10066 126047 ±41771
GM-CSF 2512 ± 1067 2973 ± 963 1786 ±684 1986 ±552
IFNy 3354 ± 1063 5209 ± 2554 2529 ± 1620 1537 ±427
TGF-p 50349 ±30161 28007 ± 13809 21871 ± 11222 14519 ± 6032
TNFa 21113 ± 13334 11681 ± 7914 7492 ± 4925 2770 ±2120
TRAF-I 11504 ± 6076 20087 ± 10563 5018 ±5134 3708 ± 1662
'Copy number ± SD, normalized to SDHA and GAPDH
Table 2: Breed, age and sex of sheep
Disease Type Sheep Breed Age (years) Sex
Multibacillary Blackface * Bleu du Maine 4.5 F
Multibacillary Blackface x Bleu du Maine 4.5 F
Multibacillary Blackface 5 F
Multibacillary Blackface 5 F
Multibacillary Blackface 3 F
Multibacillary Blackface 3 F
Multibacillary Blackface 2 F
Multibacillary Blackface 4 F
Multibacillary Blackface 4 F
Mtilriharillary Blackface 3 F
Paucibacillary Blackface x Bleu du Maine 4.5 F
Paucibacillary Texel 5 5 F
Paucibacillary Blackface x Bleu du Maine x Ueyn x Roussin 2.5 F
Paucibacillary Ueyn x Roussin 3.5 F
Paucibacillary Blackface x Bleu du Maine 4.5 F
Paucibacillary Blackface x Bleu du Maine 4.5 F
Paucibacillary Bleu du Maine 4 F
Paucibacillary Blackface x Bleu du Maine 6 F
Paucibacillary Texel 2.5 F
Paucibacillary Blackface 2.5 F
Asymptomatic Blackface x Bleu du Maine 4.5 F
Asymptomatic Blackface x Bleu du Maine 4.5 F
Asymptomatic Blackface x Bleu du Maine 7 F
Asymptomatic Blackface x Bleu du Maine 7 F
Asymptomatic Texel 1 F
Asymptomatic Blackface 2.5 F
Asymptomatic Greyface 3 F
Asymptomatic Greyface 3 F
Asymptomatic Greyface 3 F
Asymptomatic Greyface 3 F
The uninfected controls were: 6 Blackface (F) aged 4 years, 3 Texel (F) aged 4/5 years-
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Figure 5
Statistically significant changes in genes between the
three IS900+ groups and the uninfected control
group, (a) Comparison of paucibacillary and control; (b)
comparison of multibacillary and control; (c) comparison of
asymptomatic and control. Results are given as significant (p
< 0.05) fold-changes of mean copy-numbers relative to the
mean copy-numbers of the comparative group.
although the increase (xl.55 fold) of IFNy in paucibacil¬
lary ileum is not quite significant (p = 0.057). This con¬
firms that in sheep paratuberculosis polarized type l and
type 2 T cells are strongly associated to paucibacillary and
multibacillary pathology respectively. The major biologi¬
cal function of IL-18 seems to be linked to inducing type
1 responses and stimulating IFNy production |35|. Flow-
ever, the pattern of IL-18 expression is not explained sim¬
ply in terms of type 1 and type 2 responses as it is up-
regulated in both disease forms. Perhaps the increased
TGFp level in the multibacillary ileum explains the low
IFNy levels in that tissue |36],
Comparison of both disease forms to uninfected control
samples shows up-regulation of TRAF-1, IL-8, IFNy, and
TNFa, reflecting the high levels of inflammation present
in the affected tissues and agrees with the data in cattle
[21,24]. TRAF-1 is anti-apoptotic and its up-regulation in
both disease forms indicates that itmay be associated with
the accumulation of several different cell types in the lam¬
ina propria and not just macrophages |24], Previous stud¬
ies in stimulated PBMC from infected cattle have shown
down-regulation of IL-12p35 in infected cattle compared
to controls [211. However, this study showed significant
(p = 0.05) up-regulation of IL-12p40 in paucibacillary
samples (p = 0.06 for multibacillary tissue). This may be
explained by differences in the tissues tested or that IL-
12p40 levels reflect IL-23 and not IL-12p70. IL-ip and IL-
6 were also significantly raised in paucibacillary ileum
compared to asymptomatic samples, the increase in
multibacillary samples was large but without statistical
significance (p = 0.12). Both have been shown previously
to be up-regulated in multibacillary disease [371, but as
with IL-8 and TNFa they are also associated with general
inflammation. Linlike other gastrointestinal inflamma¬
tory lesions [38], the expression of large quantities of pro¬
inflammatory cytokines in paratuberculosis is not
reflected in the large scale infiltration of neutrophils. A
possible explanation for this is the presence of increased
levels ofTGFp, which has known anti-inflammatory and
immunosuppressive functions [36|. IL-3 is absent from
uninfected ileum but can be detected in both asympto¬
matic and multibacillary tissues; however, the low levels
of transcripts present leave doubt about its biological rel¬
evance. Our data only partly fit with the 'Coussens' model
of bovine paratuberculosis pathogenesis [39], They are
almost identical in relation to the T cell polarizing
cytokines and most of the inflammatory mediators but
contrasts in relation to IL-la. lhis cytokine is highly up-
regulated in infected bovine tissue and the model hypoth¬
esises that the pathogenesis of paratuberculosis may be
partly due to IL-la toxicity. However our data show that
IL-la is virtually absent from sheep ileum. Apart from
species differences a possible explanation for this discrep¬
ancy is that all the sheep paratuberculosis tissues originate
from terminal disease states and not during the develop¬
ment of the pathology.
Of particular interest is the comparison between the
infected, asymptomatic and the uninfected, control sheep.
Unlike cattle, where asymptomatic animals are regarded
as 'preclinical' and show histological lesions 119|, asymp¬
tomatic sheep show completely normal ileal histology
and their susceptibility to disease has been questioned |4|.
'Ihe normality of the asymptomatic cases is largely con¬
firmed by the fact that the majority of cytokines are
expressed at 'normal' levels; however TNFa and IL-18 are
exceptions, TNFa is significantly up-regulated and IL-18 is
down-regulated in asymptomatic samples. The low levels
of IL-18 are not matched by a similar down-regulation of
IFNy.
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Table 3: Primer sequences used for real time RT- PCR
Gene Accession number Primer Sequence 5"-3" Product
size
(bp)
IL-la F: TTGGTGCACATGGCAAGTG 72
GenBanlcNM 174092 R: GCACAGTCAAGGCTAI I I 1 ICC
IL-ip F: CCTTGGGTATCAGGGACAA 317
GenBank: XS6972 R: TGCGTATGGCTTTCTTTAGG
IL-3 F: ACCTCCTTCTGCTCCTGCTT 193
GenBanle Z18897 R: TATTCCCAAGTCCCCATrTT
IL-6 F: TCCAGAACGAGTTTGAGG 236
GenBank: X68723 R: CATCCGAATAGCTCTCAG
IL-8 F:ATGAGTACAGAACTTCGA 222
GenBank: X78306 R: TCATGGATCTTGCTTCTC
IL-IO F: CTGTTGACCCAGTCTCTGCT 305
GenBank: U11421 R: ACCGCCTTTGCTCTTGTTT
IL-I2p40 F: TCAGACCAGAGCAGTGAGGT 243
GenBank: AF004024 R: GCAGGTGAAGTGTCCAGAAT
IL-I8 F: GAGCACAGGCATAAAGATGG 241
GenBank: AJ40I033 R: TGAACAGTCAGAATCAGGCATA
IFNyq F: CTAAGGGTGGGCCTCTTTTC 55
GenBanlc X52MO R: CATCCACCGGAATTTGAATC
TNFa F: GAATACCTGGACTATGCCGA 238
GenBank: XS67S6 R: CCTCACTTCCCTACATCCCT
TGFp F: GAACTGCTGTGTTCGTCAGC 169
GenBank: X769I6 R: GGTTGTGCTGGTTGTACAGG
GM-CSF F: GATGGATGAAACAGTAGAAGTCG 261
GenBank: X5356I R: CAGCAGTCAAAGGGAATGAT
TRAFI F: AGCAGAGGGTGTTGGAGTTG 186
GenBank: XM 589090 R: CTGGGGAGAAGAGGCTGAC
GAPDH F: GGTGATGCTGGTGCTGAGTA 265
GenBanlc AF030943 R: TCATAAGTCCCTCCACGATG
SDHA F: ACCTGATGCTTTGTGCTCTGC 126
GenBanlcNM 174178 R: CCTGGATGGGCTTGGAGTAA
Conclusion
In this study, we have quantified the expression levels of
thirteen important immunoregulatory genes in the three
forms of ovine paratuberculosis using real-time RT-PCR
analyses. We have confirmed that the paucibacillary and
muitibacillary pathologies are linked to type 1 and type 2
T cell responses respectively. However, many other
cytokines are differentially expressed and it is clear that
these cytokines are part of a complex network and interact
to form the final pathologies. It is also clear that asympto¬
matic animals are also responding to infection, although
the data do not explain how the disease is controlled in
these animals. The epidemiology of the disease would
suggest a genetic susceptibility similar to that recognised
for tuberculosis and leprosy, and these data suggest sev¬
eral likely candidates for future genetic analysis.
Methods
All procedures involving animals was approved by the
Home Office under the appropriate Animals (Scientific
Procedures) Art 1986 Project Licence.
Experimental animals/tissues
Animals with the clinical disease and asymptomatic ani¬
mals were out bred sheep with naturally acquired MAP
infection from one of three farms (Table 2). Individual
sheep were delivered to the Moredun Research Institute
based on clinical symptoms of lohne's disease. All sheep
were euthanized and the diagnosis of Johne's disease was
confirmed by histopathology of the terminal ileum and
IS900 real-time PCR. Sheep from the same flocks with no
clinical signs of lohne's disease but that were positive for
IS900 were considered to be asymptomatic [4], All control
sheep tested negative for IS900. There were ten animals in
each of the infected group and nine uninfected controls.
Terminal ileum samples for histopathology were removed
post-mortem and fixed in 10% formol-saline. Four pm
sections from paraffin wax-embedded tissue were stained
with haematoxylin and eosin or Ziehl-Neelsen (ZN). For
RNA preparations, tissue blocks (~0.5 g) were placed in
five volumes of in RNAIater (Ambion, Huntingdon, LIK),
which were then incubated overnight at 4°C and then
stored at -80 °C.
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IS900 quantitative PCR
All RNA samples were tested for the presence of MAP by
IS900 real-time RT-PCR for a MAP specific insertion
sequence [40]. Primers and probes were as Eishi et al.
[41], and the reactions were carried out in an ABI Prism
7000 real-time PCR machine. Each reaction contained
12.5 pi Platinum® Quantitative PCR SuperMix-UDC, with
ROX (Invitrogen; Paisley, UK), 50 nM each primer, 100
nM probe and 5 pi cDNA, made up to 25 pi with deion-
ised water. The reactions were cycled as follows: 50°C for
2 minutes, 95°C for 10 minutes and 40 cycles of 95°C for
15 seconds, then 60 °C for 1 minute.
Isolation RNA Isolation and cDNA synthesis
Tissue samples were thawed at room temperature, 250 mg
wet weight of ileum tissue was shredded and then dis¬
rupted and homogenised in a buffer containing 4 M gua-
nidine isothiocyanate using a ribolyser (Fast-Prep from
Thermo-Hybaid, Runcorn, UK). Total RNA was extracted
using a Qiagen RNeasy* Maxi Kit (Qiagen, Crawley, UK)
and DNase treated using the Ambion DNase I kit
(Ambion, Huntingdon, UK). Samples were eluted into
800 pi of nuclease-free water. The RNA was quantified by
spectrophotometry, ethanol precipitation and resus-
pended in 300 pi of nuclease-free water. Samples were
checked for genomic DNA contamination by GAPDH
PCR.
For cDNA synthesis, 2.5 pg of RNA was diluted to a final
volume of 16.25 pi in nuclease free water. 500 ng ofOligo
(dT) (Promega, Southampton, UK) was added, and incu¬
bated for five minutes at 70°C, followed by five minutes
on ice. To this 5 pi of 5x MMLV buffer, 1.25 pi of 100 mM
dNTPs and 1 pi of MMLV RT enzyme (Promega) were
added, and the mixture was incubated at 42 °C for 60 min¬
utes, followed by 15 minutes at 70°C to inactivate the
enzyme. The cDNA was diluted four-fold in nuclease free
water and stored at -20°C until used.
Cloning of ovine cytokine gene fragments
Primers (Table 3) were selected and designed using
Primer3 [42] software. All selected primer sequences were
then checked for possible cross-hybridization using the
BLAST [43] and subjected to quality check using Net
Primer [44], The PCR uiixluie contained 2 pi of cDNA; 5
pi (10x) PCR buffer (Promega);l pi dNTPmix (Promega);
20 pmol of each primer (Sigma-Genosys, Haverhill,
UK);1 pi Taq polymerase (5 units) and nuclease free water
was added to a final volume of 50 pi. Reactions were then
cycled under the following conditions: 95°C for 2 mins
30 cycles of 30 s at 95°C, annealing at (see Table 1), 45 s;
60 s at 72°C, followed by a final extension at 72°C for 5
mins. PCR products were analysed by agarose gel electro¬
phoresis, visualized by ethidium bromide/lIV transillu
mination, purified using the QlAquick" system (Qiagen),
cloned into pGEM T-Easy* (Promega) and sequenced.
Quantitative real-time PCR
Two-step, quantitative real-time RT-PCR was carried out
using a Rotor-Gene™ 3000 (Corbett Life Science, Cam¬
bridge, 11K) using primers as in Table 3. Standard curves
for each gene were generated using 10-fold serial dilution
series of linearized plasmid DNA templates. Quantitative
real-time PCR reactions were run in 20 pi containing 2 pi
of FastStart Taq buffer, 200 pM dNTPs (Promega), 250
nM each primer, MgCl2 to an optimum concentration,
0.7 pi of a 1/1000 dilution ofSYBR green mastermix, 0.75
LI FastStart Taq DNA Polymerase(all Roche Diagnostics,
1 ewes, LIK) and 2 pi of template cDNA, made up to 20 pi
with deionised water. The cycling conditions for all genes
were as follows: 5 minutes at 94°C, 45 cycles of 20 sec¬
onds at 94 °C, 20 seconds at 60 °C and 20 seconds at
72°C, followed by a melt curve starting at 65°C rising to
94°C at 0.3 °C per second. Copy numbers were deter¬
mined from the Ct values of each sample in comparison
to the copy number values assigned from the plasmid
DNA standard using Rotor-Gene analysis software
(6.0.34). Data were normalized using gIyceraldehyde-3-
phosphate dehydrogenase (GAPDH) or succinate dehy¬
drogenase (SDHA) housekeeping genes. A normalization
factor was calculated taking into account the 75th percen
tile of the housekeeping gene copy numbers for each run.
Results were compared pair wise using a 2-sample t test to
determine statistical significance. Each sample was ana¬
lysed in duplicate, n = 10 for each IS900+ sheep and n = 9
for the uninfected controls.
Variability assay
To determine the level of variability inherent in the real
time PCR reactions, a variability assay was carried out. A
single sample was reverse transcribed in three simultane¬
ous reactions. The cDNA produced was then amplified ten
times each in an SD1IA real-time PCR reaction. The result¬
ing copy numbers were compared to give a value for the
variability inherent within the reactions. The assay
showed that the overall variability inherent to the method
is 2.2 fold.
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